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ABSTRACT
Fractions exhibiting activity detrimental to the
killing function of activated bovine monocyte/
macrophages towards Candida albicans were obtained from
Mycobacterium paratuberculosis.

Active fractions were

initially derived by ultrasonication of bacterial
samples followed by ammonium sulfate precipitation,
ion-exchange chromatography, gel filtration
chromatography, heat precipitation, acid precipitation
and alkali treatment.

Two different fractions that

exhibited marked inhibition of macrophage killing
ability were derived and partially characterized.
Novel methodology was developed to accomplish the
task of lysis and fractionation of mycobacteria
utilizing the Matrix Solid Phase Dispersion (MSPD)
technique that appeared to be much more efficient and
is certainly less time consuming and less expensive
than classical methodologies.

Fractionation of

cellular components were confirmed by analysis of the
solvent extracts by SDS-PAGE, Markwell protein
determination, High Pressure Liquid Chromatography
(HPLC) and Gas Chromatography/Mass Spectrometry
(GC/MS).

By making minor modifications in the MSPD

technique both genomic and plasmid DNA were obtained in
partial purity.

The DNA samples were further purified

using classical methodology to obtain DNA that was
amenable to restriction endonuclease digestion with
yields comparable to those of classical means.
By utilizing the MSPD technique for lysis and
fractionation of mycobacteria, two &*. par atuber cu 1os is
strain 18 MSPD fractions demonstrating marked
inhibitory activity towards the killing function of
macrophages were obtained (ACN and H20 MSPD extracts).
Further fractionation by centrifugal filtration and by
Concanavalin A affinity chromatography demonstrated as
many as three compounds that show macrophage inhibitory
activity.

All of the active fractions appear to be

combinations of carbohydrate and lipid (glycolipids)
with proteinaceous components either being minimal or
absent.

Preliminary plasma desorption mass spectral

data suggests that one fraction may be a mixture of
mycolic acids, while the other two fractions contained
mannosyl and/or glucosyl functional groups.

x

CHAPTER 1

LITERATURE REVIEW AND OBJECTIVES

General

Bovine paratuberculosis is a chronic,
debilitating, granulomatous, enteric disease caused by
infection with the acid-fast bacillus Mycobacterium
paratuberculosis.

The disease was first described by

Johne and Frothingham in 1895, (Johne and Frothingham,
1895) therefore the name Johne's disease.

The organism

was first isolated by Twort in 1910 (Twort and

Ingram,

1912) and named Mycobacterium enteriditis chronicae
pseudotuberculosae bovis iohne.

The disease later

became known as bovine paratuberculosis as well as
Johne's disease and the causative organism was renamed
Mycobacterium paratuberculosis.

Historically, the

condition has been known by a number of different
names, including "paratuberculosis", "scrapie",
"chronic enteritis" and "shooting" (Merkal, 1984).

In

years past, JL paratuberculosis has come under scrutiny
as to whether or not it is a separate species or an
antigenically defective variant of 1L_ avium (Camphausen
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et al■. 1988).

However, recently

paratuberculosis

strain 19698 has been shown by DNA probe analysis to be
a distinct mycobacterial species (McFadden g£ al..
1987a&b; Green gt al.. 1989); whereas, M.
paratuberculosis strain 18 has been shown to be
indistinguishable from IL. avium serovar
a l.. 1987a).

(McFadden et

IL. paratuberculosis has also been

incriminated as a causative agent for Crohn's Disease
(regional ileitis) in man (Chiodini et al.. 1986;
Chiodini et al.f 1984a; Chiodini et al.. 1989);
however, a serologic response to the organism was
lacking in the sera of active Crohn's patients
(Kobayashi et al.. 1988).
Most research related to It paratuberculosis has
been aimed at the development of an accurate testing
procedure (Yokomizo et al.. 1983; Jorgensen et al.f
1979; Sikes, 1953; Larsen gt al.. 1965A; Larsen gt al..
1963; Larsen et al.. 1965B), treatment (Rankin, 1953;
Whitlock gt al.. 1983; Kreeger gt al.. 1988; Larsen et
al.. 1952), vaccine production (Larsen, 1950; Larsen,
1974; Stuart, 1965; Larsen gt al♦. 1978; Merkal, 1984)
and immunologic mechanisms (Merkal gt al.r 1970;
Kreeger gt al.. 1988; Momotami gt al.. 1988).

More

recently highly specific DNA probes for detecting the
IS900 Hi. paratuberculosis specific insertion sequence
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and the polymerase chain reaction (PCR) are being used
for rapid and specific diagnosis of Johne's disease
from bovine feces (Vary et al.f 1990).

-Incidence and Economic Significance

Paratuberculosis is primarily a disease of
domestic ruminants throughout the world.
of wildlife (Chiodini et al.. 1983;

Many species

Jessup gt al..

1981; Williams et al.. 1983; Thoen g£ al.. 1977) and
monogastric domestic animals (Larsen et al.f 1971;
Rankin, 1956; Ringdal, 1963; Larsen et al.. 1972) have
also been naturally or experimentally infected.
Paratuberculosis was first described in North
America in 1908, although it had probably been present
much earlier (Hole, 1958).

In the United States, it is

estimated that the prevalence of infection is between
5% to 20% and that losses to the dairy industry exceed
$1.5 billion per year (Merkal, 1984).

In a 1981 survey

of Illinois cattle, an incidence of 31-35% was reported
(McPherron, 1981; McPherron et al.. 1982; McPherron et
a l .. 1983).

In a 1983 Wisconsin abattoir survey of

1,000 cattle, the prevalence was determined to be 11%
with annual losses estimated at $54 million (Arnoldi
and Hurley, 1983).

A prevalence rate of 18% was
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observed in a 1986 survey of New England cattle with
annual losses estimated at $ 15.4 million (Chiodini and
Van Kruiningen, 1986).

In a

nationwide survey of

7,540 animals using culture methods, the prevalence was
reported to be 1.6% (Merkal, 1987).

In Louisiana, a

recent survey in beef cattle herds revealed that 4.4%
of the animals tested and 30% of the herds tested were
seropositive on the ELIZA test with an estimated annual
loss to the beef industry of $ 2,003,710.00 equating to
a loss of approximately $ 450.00 per Louisiana producer
per year (Turnquist et al.. 1988).
Several areas of the United States have a high
incidence of the disease; however, cattle producers
often demonstrate either a lack of knowledge and/or
concern of preventing spread of the disease.

Known

infected animals and herds are often sold at auction
allowing spread to non-infected herds.

Since some

producers often prefer not to acknowledge the presence
of paratuberculosis, it is difficult to assess the
incidence and overall economic impact of the disease.
In addition to death losses, infected animals often are
culled due to decreased productivity, increased
incidence of other infections and infertility (Kopecky
et al., 1976; Merkal gt al., 1975).

In one study of

infected animals, 29.9% were culled due to clinical
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disease and 70.1% were culled due to other problems
such as mastitis (15.9%), infertility (37.3%) and other
reasons (16.9%) (Merkal et al.. 1975).

Microbiology

Mycobacterium paratubercu1osis is a small (0.5 x
1.5 Atm), gram-positive, facultative, acid-fast bacillus
(Sneath et al.. 1984).

The organism grows slowly and

requires mycobactin for in vitro cultivation.
Mycobactins are a family of compounds within a larger
group of iron-binding hydroxyamate compounds that
function as siderophores and are produced by a wide
range of bacterial species (Snow, 1970; Neilands and
Ratledge, 1982).

These mycobactins help the

mycobacteria survive by scavenging and robbing iron
from the host.

Iron is necessary for the function of

several metabolically important, iron-containing
enzymes and is essential to respiration (Locke et al.f
1932).

Over 13 different mycobactins have been

identified, including mycobactin I, from M.
intracellulare; Av, from H*. avium; J from M.
paratuberculosis strain 18; P, from &*. phlei; T, from
M. tuberculosis; and S, from £L_ smecrroatis (Merkal et
al.. 1981; Ratledge and Stanford, 1982).

The
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incorporation of Mycobactin J into culture media
greatly increases the growth rate of M.
paratubercu1osis allowing development of visible
colonies on solid media within 4 to 8 weeks (Chiodini
et al.. 1984a).

Mycobactin dependency can be, at

least, partially circumvented by the addition of ferric
iron to culture media (Snow, 1970).

Positive

identification is still currently based on slow growth
and mycobactin dependence ? however, a recently
developed DNA probe specific for an insertion sequence
found only in H*_ paratuberculosis (IS900) holds great
promise for accurate and rapid identification (Green et
al.f 1989; Vary et al.. 1990).
Mycobacterium paratubercu1osis is typically
cultivated from feces on Herrold's egg yolk medium
supplemented with at least 2.0 #xg/ml mycobactin J.
This usually requires a decontamination step

that

utilizes either hexadecylpyridium chloride (HPC) or
benzalkonium chloride to destroy contaminants; however,
both compounds also mildly inhibit the growth of M.
paratuberculosis.

HPC (0.75% solution overnight) is

currently the decontamination

agent of choice ?

however; it has also been shown to reduce viable
numbers of £L_ paratuberculosis by approximately 100fold (Hamilton et a l .. 1989).

Even with the inclusion
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of a decontamination step, saprophytic overgrowth of
slants occur frequently.

Middlebrook's 7H9 or 7H10

media broth supplemented with mycobactin J is the
medium of choice for cultivating large quantities of
the bacterium (Merkal et al.. 1981).

Clinical Features

Infected animals rarely show clinical signs
earlier than 2 years or greater than 7 years of age
with the Channel Island and beef Shorthorn breeds being
particularly susceptible (Chiodini et al.. 1984a).

In

Louisiana, the Brahman breed appears to be infected
most frequently; however, this is probably due to the
greater numbers of Brahman and Brahman-cross cattle in
Louisiana versus Channel Island breeds.

The disease

spreads slowly and may be present in a herd for years
prior to diagnosis (Chiodini et al. . 1984a; DeLisle et
al.. 1980a&b; Larsen et al.. 1963a&b; Larsen et al.
1965).

It has been shown that by the time the first

infected animal is diagnosed, 38-42% of the herd is
already infected (Delisle, 1980; Larsen et al..
1963a&b; Larsen et al.f 1965).
Clinical signs usually begin as a non-responsive
chronic or intermittent, often profuse, diarrhea and
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progressive wasting with periods of remission that may
last for weeks or months.

Clinical remission is often

associated with pregnancy with clinical signs resuming
shortly after parturition (Chiodini £t al.. 1984a).
Several stress factors including parturition, poor
nutrition, high milk production and grazing on mineral
deficient low-lying wetlands have been associated with
precipitating clinical disease (Allen £t al.. 1968;
Downham, 1950; Macindoe, 1950; Smyth, 1935).

Appetite

is usually good and there may be an intermittent fever.
During the terminal stages of the disease the diarrhea
may become bloody.

There is loss of appetite, severe

emaciation, ventral edema, anergy and bacteremia
(Chiodini et al.. 1984a).

During anergy, the organism

may invade the cotyledons and result in abortion (Omar
et al.. 1967); however,

transuterine spread and

subsequent development of the disease in the fetus has
not been documented (Chiodini et. al.. 1984a).

Death is

the usual outcome since treatments have either been
impractical or ineffective; however, some
experimentally infected animals have been reported to
recover (Larsen et al.. 1975; Taylor, 1953; Karpinski
and Zorawski, 1975; Rankin, 1959).

Pathology

It is commonly known that clinical signs and the
severity of gross and histological lesions rarely
correspond (Smyth and Christie, 1950; Allen et al..
1968; Downham, 1950; Macindoe, 1950; Smyth, 1935;
Hallman and Witter, 1933).

This is especially true

with the Brahman and Brahman-cross breeds.

Primary

gross lesions in cattle are confined to the intestinal
tract where they may extend from the duodenum to the
rectum; however the terminal ileum is the most common
site.

The regional lymph nodes are also involved and

there may be effusion into body cavities, serous
atrophy of fat and dependent subcutaneous edema.

The

affected intestine is usually thickened, corrugated and
highly folded.

The intestinal folds remain, even when

the intestine is stretched.

The histologic lesion is

described as a diffuse granulomatous enteritis, without
necrosis, hyperemia or reactionary fibrosis (Hallman
and Witter, 1933; Bang, 1906; Buerget et al., 1978;
Taylor, 1953).

In animals infected with pigmented

strains of JL-. paratuberculosis. the intestinal mucosa
may also take on an yellow-orange cast (Taylor, 1953;
Taylor, 1957; Stuart, 1965; Watt, 1954).

In younger

animals there may be a hemorrhagic enteritis without
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intestinal thickening (Smyth, 1951).

Regional lymph

nodes are enlarged, affected lymph nodes demonstrate a
granulomatous lymphadenitis and mesenteric lymphatics
may be enlarged.

Secondary lesions may occur in other

organs with the liver being the most common secondary
site (Hallman and Witter, 1933; Mathews, 1930; Buergelt
et gL., 1978).
Early granulomatous infiltrates in the intestine
may be nodular (tuberculoid); however, these usually
rapidly coalesce to form diffuse (lepromatous)
infiltrates (Chiodini et al.f 1984a).

The earliest

lesions observed in experimentally infected calves are
focal aggregates of macrophages in Peyer's patches and
in the villous tips (Gilmour g£ al., 1965; Payne and
Rankin, 1961a&b).

The lamina propria and often the

submucosa of the intestine are variably infiltrated
with large epitheloid macrophages containing abundant
foamy cytoplasm.

Giant cells of primarily the

Langhan's type are often observed.

Both the epitheloid

macrophages and giant cells may contain variable
numbers of typical acid-fast bacilli (Buergelt and
Nguygen, 1983; Harding, 1957; Rajya and Singh, 1961;
Hallman and Witter, 1933; Buergelt et al.f 1978; Stamp
and Watt, 1954).
The regional lymph nodes demonstrate multifocal
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coalescing aggregates of epitheloid macrophages and
giant cells primarily within the cortex.

Variable

numbers of typical acid-fast bacilli are observed.
There may be multifocal granulomas and/or granulomatous
pericholangitis within the liver; however, acid-fast
bacilli usually cannot be demonstrated (Hallman and
Witter, 1933; Mathews, 1930).

Arteriosclerosis with

calcification and plague formation commonly occurs in
the trunk of the aorta and the heart of infected
animals (Levi, 1948; Stamp and Watt, 1954; Nakamatsu et
al.. 1968; Alibasoglu

al.. 1968).

A fibrinoid or

amyloid-like substance is sometimes observed in small
vessels, lymph nodes, adrenals, udder and renal
glomeruli (Chiodini et al.r 1984a).

Pathogenesis and Immunity

Usually many organisms are passed in the feces of
infected animals and persistant carriers which serve as
the primary sources of infection for neonatal animals
(Larsen, 1972).

The incubation period for

paratuberculosis is variable and often protracted,
ranging from 4 months to 15 years ( Macindoe, 1950;
Smyth and Christie, 1950).

After ingestion, the

organism penetrates the intestinal mucosa and regional
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lymphoid tissues, is phagocytized by macrophages and
tends to localize initially within the Peyer's patches
of the ileum and the ileocecal lymph nodes (Gilmour et
al., 1965? Payne and Rankin, 1961a&b; Momotami e£ al..
1988).

The M cells of the dome epithelium within

Peyer's patches are the primary site of entry (Monotami
et al. . 1988).

A primary bacteremia ensues with

subsequent localization to secondary sites including
the liver, spleen and lymph nodes.

The organism

somehow is protected intracellularly within the
macrophages against humoral and cellular defense
mechanisms (Momotami et al.. 1988? Zurbrick gt al..
1987).

An intermittent, profuse, chronic, diarrhea

follows because of a multifocal, eventually
generalized, chronic, progressive, granulomatous,
enteritis and lymphadenitis.

Bacteremia and anergy

develop in the terminal stages of the disease (Chiodini
et al.. 1984a).

The possibility of congenital

infections have been postulated since the organism has
been recovered from testes (Tunkl and Aleraj, 1965),
semen (Tunkl and Aleraj, 1965? Larsen and Kopecky,
1970? Larsen e£ al.. 1981? Lukashaw gt al.. 1962),
bulbourethral gland (Larsen and Kopecky, 1970),
prostate, seminal vesicles (Larsen and Kopecky, 1970?
Larsen et al.f 1981), mammary gland (Doyle, 1954?
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Goudsward, 1970; Taylor et al., 1981), uterus
(Goudsward, 1970; Kopecky et al.. 1967; Lawrence, 1956;
Pearson and McCelland, 1955) and fetus (Lawrence, 1956;
Pearson and McCelland, 1955; Doyle, 1958; Muhammed and
Eliasson, 1979) of the bovine.

As many as 35% of

infected animals may shed the organism in milk (Hole,
1958; Goudsward, 1970; Taylor et al.. 1981).
The organism survives and reproduces within
macrophages initially within the Peyer's patches and
the mucosa of the ileum and later forms diffuse
infiltrates in the ileal submucosa (Chiodini e£ al..
1984a).

It is generally accepted that after the

mycobacterium is phagocytosed, phagosome-lysosome
fusion with the release of hydrolytic enzymes does not
occur (Sibley et al.. 1987); however, controversy
exists on how to evaluate phagolysosomal fusion (Goren
et al.. 1987A; Armstrong et al.. 1975; Armstrong et
al.r 1971; Hart et al., 1988; Goren et al.. 1987B;
Frehel et al.. 1986).

The mechanism by which this

inhibition occurs remains unknown.

Evidence has been

presented that a virulent strain of JjL. tuberculosis can
disrupt the phagosomal membrane and appear free in the
cytoplasm of infected alveolar macrophages; whereas, an
avirulent strain could not (Myrvik et al.f 1984).
Mycobacteria have been shown to be killed and cleared
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by activated macrophages and they are susceptible to
the toxic effects of the peroxidase-H202-halide
antimicrobial systems of phagocytes (Klebanoff
1984; Sibley et al., 1987).

al..

Macrophages burdened with

large numbers of EL. leprae are refractory to activation
by gamma interferon, a potent activator of macrophage
function, while macrophages containing only a few
organisms could still be activated (Sibley et al..
1987; Shevach, 1984; Murray et al.. 1983).
Information on the specific humoral and cellular
immunology of Johne's disease is limited when compared
with other mycobacterial diseases.

However, the

immunity to tuberculosis from the perspective of
pathogenesis has been well described (Wiegeshaus et
al.f 1989).

Antigens specific for IL paratuberculosis

infected tissues in sheep were evaluated in the 1940's
but, only limited progress has been made towards
eliminating the disease (Sigurdsson, 1945; Sigurdsson,
1946; Sigurdsson, 1947A; Sigurdsson, 1947B).

The

clinical signs in cattle are thought to be primarily
due to a delayed-type hypersensitivity reaction in
response to products or components of the organism
(Merkal and Witzel, 1973).

Infected animals may

demonstrate a humoral response, cell-mediated response,
both humoral and cell-mediated responses or anergy
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(Bendixen, 1978).

Cattle with active immunologic

responses usually harbor few organisms and often
exhibit marked delayed-type hypersensitivity to
intradermal

tests with johnin and/or avian tuberculin

(Chiodini gt al.. 1984a; Merkal, 1984).

Animals

infected with moderate numbers of organisms usually
exhibit lesser reactions to intradermal testing and in
animals with intestinal lesions heavily laden with
bacteria there is often no reaction following
intradermal injection of johnin or avian tuberculin,
thus indicating anergy (Merkal, 1984).
Initially in the course of the disease, there is a
cell-mediated response and, as the disease progresses,
a humoral response ensues that is thought to be the
result of intact bacteria and bacterial components from
degenerate and dead macrophages (Chiodini gt al..
1984a).

The early response (cell-mediated) usually

presents in the form of a tuberculoid reaction and is
generally considered to be associated with a competent
immune system.

The later (humoral) response presents

as a lepromatous reaction and is usually associated
with an incompetent immune system (Chiodini g£ al.f
1984a).

The mechanism by which anergy occurs in the

later stages of the disease is unknown and has not been
thoroughly investigated.

The release of soluble
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mycobacterial products or components and the release of
mediators from macrophages as occurs with

leprae

infections are probably involved (Zurbrick et al..
1988; Birdi et al.. 1981; Salgame gt al.. 1981).
Antigen-antibody reactions in the infected
intestine may cause significant histamine release, thus
exacerbating the diarrhea (Merkal gt al.. 1970).

Whole

blood, white blood cells and plasma from febrile,
infected animals have been shown to passively transfer
johnin hypersensitivity to noninfected calves (Merkal
and Witzel, 1973).

Factors from the plasma of patients

with leprosy and paratuberculosis have been shown to
suppress in vitro lymphocyte transformation (Davies et
al.. 1978; Bullock, 1968).

Resistance

It is estimated that only one-third of exposed
animals become infected.

Development of the disease is

dependent on the size of the exposure dose and the
immune status of the host (Chiodini gt al ., 1984a).
Animals less than one-year-old appear more susceptible
to infection (Doyle, 1953) and animals infected as
adults either eliminate the organism, become carriers
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or develop mild clinical disease (Chiodini et al.f
1984a).

Most animals are infected at less than 30

days-of-age and experimental inoculations suggest that
infection must occur early because of the development
of age-related resistance (Bendixen, 1978; Doyle, 1953;
Doyle 1956; Hagan, 1938; Larsen e£ al.. 1975; Levi,
1948; Rankin, 1958; Rankin, 1961a&b; Rankin, 1962;
Taylor, 1953).

The mechanism by which age-related

resistance occurs is, at present, still unknown.

The

susceptibility of mice to the establishment of
mycobacterial infections has recently been shown to be
controlled by a single, dominant, autosomal gene called
the Beg gene.

This Beg gene regulates directly the

process of T cell-independent macrophage activation for
antimycobacterial function and, indirectly, the quality
and magnitude of the specific immune response to
Mycobacterium bovis (Skamene, 1989).

It is thought

that the Beg resistant allele confers to the macrophage
the ability to inhibit the proliferation of the
mycobacterium (Frelier, 1990).

Similar genetic

resistance has been described for Mycobacterium
intracellulare (Goto gt al.. 1984).

The Beg resistant

macrophages (Swiss mouse) possessed superior accessory
functions in supporting antigen-induced and mitogen
induced T cell proliferation as compared with Beg
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susceptible macrophages (C57BL/6J mice).

The Beg gene

is thought to be located on the centromeric portion of
chromosome 1 within a linkage group that has some
homology with a conserved region in human chromosome 2
(Skamene, 1989).

Natural resistance of mice to the

intracellular pathogens Leishmania donovi f Salmonella
tvphimurium.

bovis. £L. intracellulare. MU

tuberculosis and MU lepraemurium is thought to be
regulated by the same or closely linked genes on
chromosome 1 (Frelier et al.. 1990).

Studies have

also demonstrated that C57BL/6J mice are more
susceptible to infection by MPARA than are the Swiss
mouse and genetic investigation suggests that either
the same locus regulates resistance to MPARA and M.
bovis or the phenomena are regulated by linked loci
(Frelier et al.f 1990).

This phenomena has yet to be

demonstrated in cattle and, if demonstrated, may play a
major role in the control of paratuberculosis through
the development of resistant breeds of cattle.

Diagnosis and Prevention

Many diagnostic methods have been employed for the
diagnosis of paratuberculosis.

These include

intradermal and intravenous johnin tests, complement
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fixation, hemagglutination, agar gel immunodiffusion,
enzyme-linked immunoabsorbant assay (ELIZA),
radioimmunoassay, fluorescent antibody, lymphocyte
transformation, migration inhibition, leukocyte
migration, immunoperoxidase, mucosal and lymph node
biopsy and fecal culture (Chiodini gt al.. 1984a).

Not

one of the above tests has proven completely reliable
due to varying percentages of either false positives or
false negatives.

Fecal culture is still considered the

most accurate definitive method; however, results are
not obtained for 3 - 4

months.

With the advent of

recombinant DNA probes and the polymerase chain
reaction (PCR), a new dimension in the diagnosis of
various disease states, including paratuberculosis are
rapidly becoming available.

A recently developed DNA

probe specific for an insertion sequence (IS900), found
only in IL paratuberculosis strain 19698, in
conjunction with PCR holds great promise for accurate
and rapid identification of as little as 1 to 10
organisms per gram of feces or tissue (Green gt al..
1989; Vary et al.. 1990).
A number of bacterins, both attenuated and
unattenuated have been developed (Doyle, 1945; Gilmour
and Brotherston, 1966; Hagan, 1935; Larsen , 1950;
Larsen gt al.; 1974; Stuart, 1965).

Heat-killed
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bacterins (Brotherston et al.. 1961; Huitema, 1968?
Larsen et al.f 1978) and disrupted fragments of M.
paratuberculosis (Gilmour and Brotherston, 1966; Larsen
et al.. 1978; Larsen gt al.. 1969) have been used but
the effectiveness of these vaccines has been disputed.
Vaccination does not confer absolute immunity as some
vaccinated animals may shed the organism or develop the
disease (Hagan, 1935; Larsen et al., 1974; Brotherston
et al. . 1961; Huitema, 1968? Larsen et al.. 1978;
Larsen et al.. 1969; Doyle, 1964).

A major

disadvantage to vaccination is that the vaccinated
animals develop hypersensitivity to johnin, avian PPD,
tuberculin and H j. bovis PPD, which may create problems
with tuberculosis testing and state and federal
regulatory programs (Larsen, 1965).
Model vaccines for various mycobacterial diseases
have consisted of killed, live nonvirulent strains or
live attenuated strains of mycobacteria (Gelber et al..
1990).

Immunization has often afforded little

protection although many compounds associated with the
mycobacterial cell wall are highly immunogenic (Orme et
al.. 1984; Orme, 1988; Chatterjee et al., 1988;
Chandramuki et al.. 1989? Gaylord et al.. 1987).
Recently effective immunization of mice against M.
leprae has been achieved using cell wall fractions
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progressively depleted of lipids, carbohydrates and
soluble proteins (Gelber gt al.f 1990).

This is the

first evidence that vaccination with mycobacterial
subunits protects mice against leprosy bacilli and may
provide the foundation for production of vaccines for
other mycobacterial diseases (Gelber gt al.. 1990).

Treatment and Control

Mycobacterium paratuberculosis is susceptible to
many antituberculous drugs in vitro.

However, various

treatment regimens have generally been unsuccessful as
infected animals continue to shed the organism and
eventually succumb to the disease (Gilmour, 1968;
Gilmour, 1971; Hintz et al.. 1983; Larsen and Vardaman,
1953; Micheal, 1946; Rankin, 1953; Spicer, 1936;
Whitlock et al.f 1983; Larsen and Vardaman, 1952;
Kreeger et al.. 1988).
The insidious long-term nature of the disease
makes it one of the most difficult diseases to control
and eradicate.

Currently, there is no federally

regulated control or eradication program for bovine
paratuberculosis.

Eleven states ( AZ, CO, GA, MN, MS,

NH, NM, NC, SD, UT and WY) quarantine infected herds,
fifteen states (AR, CT, IL, IN, IA, LA, MD, MA, MT, ND,
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PA, RI, SC, TN and VA) quarantine infected animals only
and 24 states have no established programs (Chiodini et
al.. 1984a).
Two control options are currently available.
First, the herd may be totally depopulated, premises
must be thoroughly cleaned and disinfected, outside
paddocks must be plowed under and covered with fresh
topsoil and grazing on infected pastures must be
restricted for six to twelve months after depopulation
(Marsh, 1952).

The second option is to test all adult

animals in the infected herd by fecal culture every six
months and eliminate (slaughter) those positive animals
which have the greatest potential of being heavy
shedders (Dimock, 1952; Larsen, 1972; Moyle, 1975).
Thirteen basic management practices for the effective
control and eradication of paratuberculosis have been
described (Chiodini gt al.. 1984a).
are;

(1)

As summarized they

biannual fecal culture testing; (2)

slaughter of all shedders and clinically infected
animals, including their offspring; (3)

thorough

cleaning of contaminated areas and equipment; (4)
plowing over of contaminated paddocks and feedlots; (5)
sterilization of manure with lime; (6)

mowing of

pastures to allow greater exposure to sunlight; (7)
fencing off or draining stagnant water; (8)
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segregation of calves immediately after birth and
raising them in an uncontaminated environment; (9)
feeding calves pasteurized colostrum; (10)

feeding

young animals pasteurized milk or milk replacer; (11)
pasturing young stock or restocking animals only in
uncontaminated areas;

(12)

prevention of cross

contamination by wearing clean garments and equipment;
and (13)

mixing of young stock with adults only after

they are over one year-of-age.

Macrophage function

Controversy surrounds the role and function of the
macrophage in mycobacterial infections.

Much of this

controversy may be attributed to the fact that most
studies have been performed on blood-derived
monocyte/macrophages instead of those participating in
the local lesions (Kreeger, 1988).

Macrophages

infected with various mycobacteria demonstrate
decreased ability to kill other bacteria and to
phagocytize zymosan (Cree and Swanson-Beck, 1986; Birdi
et al.. 1983; Sibley et al.. 1987).

Infected

macrophages are also known to inhibit lymphokine
production and lymphocyte blastogenesis (Suko gt al..
1985).
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Macrophages are responsible for the production of
Interleukin-1 (IL-1) which stimulates T-cells to
secrete Interleukin-2 (IL-2) and express receptors
(Smith fit al.f 1980; Robb fit al.. 1981; Mizel, 1982;
Puri gt al.. 1980).

In lepromatous leprosy, patients

demonstrate an increase in prostaglandin E2 production
which is a potent inhibitor of IL-1 production (Kunkel
and Chensue, 1985).

This effect can also be

demonstrated in vitro with

leprae stimulated

macrophages from lepromatous patients (Ridel et al..
1986).

Interleukin-1 a primary mediator of the acute-

phase response to inflammation, infection and injury,
may regulate a large number of processes throughout the
body (Otterness et al.. 1989).
It has been well documented that gamma interferon
(IFNt) is the lymphokine that activates macrophage
oxidative metabolism and antimicrobial activity towards
several microorganisms including; Toxoplasma aondi.
Trympanosoma crugjL, Leishmania donpvi, Chlamydia
psittaci and Candida spp. (Nathan et al.r 1983;
Rothermel fit al., 1983).

However, in a study with IFNt

treated, cultured murine peritoneal macrophages
utilizing Mycobacterium bovis BCG

as the eliciting

agent, activation as measured by hydrogen peroxide
production did not occur.

However, when thioglycolate
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was used as the eliciting agent a dramatic increase in
hydrogen peroxide was observed (Sharp and Banerjee,
1986).

It has been reported that macrophages from

lepromatous leprosy patients were deficient in hydrogen
peroxide production.

However, when these same

macrophages were pretreated with IFNt , they responded
in a similar fashion as macrophages from normal
individuals (Kaplan et al.. 1986).

This study

concluded that the effect was independent of prior
macrophage ingestion of JL. leprae bacilli and that the
immune defect was a lack of response to 8L. leprae by
the patient's T-cells and not a defective response of
macrophages to IFN t .

Krahenbuhl has demonstrated that

live but not formalin-killed &*_ leprae induced a
refractory effect in murine peritoneal macrophages that
was dependent on the number of viable bacilli within
the macrophage (Krahenbuhl, 1990).

This refractory

effect was evident by failure to stimulate enhancement
of microbicidal activity, cytotoxicity for tumor cells,
superoxide production and surface la antigen
expression.

It was also demonstrated that if treatment

with IFNt occurred simultaneously or prior to H*. leprae
infection, macrophages appear to become fully active
(Krahenbuhl, 1990).
In bovine monocyte/macrophages infected with 1L.
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paratuberculosis and continuously incubated with crude
bovine IFN and recombinant bovine IFNa, significant
restriction of intracellular growth occurred.

No

effect was observed on phagocytosis and no obvious
relationship was observed between the release of
superoxide anion and the intracellular fate of the
bacilli (Zubrick et al.f 1988).

Biologically Active Components of Mycobacteria

The prominent glycolipid containing capsule of the
mycobacteria is thought by some researchers to form an
indigestible, hydrophobic interface between the
bacterium and the host cell, thus preventing
intracellular digestion (Draper et al.f 1970; Brennan,
1983).

Phenolic glycolipids from several strains of

mycobacteria are potent inhibitors of lymphocyte
proliferation in a concentration dependent manner and
the inhibition is independent of the stimulus used.
The mechanism appears to be due to a nontoxic
functional effect on proliferating CD4+ lymphocytes.
The effect is nonspecific and the inhibition may be a
general property of the glycolipid (Fournie et al..
1989).

Phenolic glycolipids isolated from M_=_ leprae.
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M. tuberculosis and

bovis (i.e.PGL-I) have been

shown to be highly immunogenic, useful for serological
diagnosis and to have significant deleterious effects
on phagocytes (Brennan, 1989; Chatterjee, gt al..
1989A; Chatterjee, et al. 1989B; Gormus gt al.f 1988;
Gelber gt al.. 1989).
Mycobacterial lipoarabinomannan (LAM) is also a
potent inhibitor of in vitro proliferation of human
peripheral blood mononuclear cells (Ellner and Daniels,
1979) and of gamma interferon mediated activation of
mouse macrophages in vitro (Sibley gt al.. 1988).

The

mycobacterial LPS's , 1ipoarabinomannan (LAM) and
mycolylarabinogalactan, are inherently part of the
mycobacterial cell wall, highly immunogenic and known
to inhibit phagocyte function (Brennan, 1989; Gelber et
al .r 1989; Kobayashi et al.. 1988).

Lipoarabinomannans

are widely distributed among mycobacteria where they
are covalently linked to phosphoinositol in the cell
membrane and are the major immunogens recognized by
sera of infected patients (Hunter gt al.f 1986; Misaki
et al. . 1977).

Gamma interferon, but not Interleukin-4

or Tumor Necrosis Factor has been shown to activate
tuberculostatic functions in murine macrophages against
M. bovis (Flesch and Kaufmann, 1990).
Immunosuppressive results have been demonstrated
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with the glycopeptidolipids of Mycobacterium aviumintracellulare complex, which also interfere with
subsequent proliferation of murine lymphocytes (Fournie
et al., 1989; Brownback and Barrow, 1988; Tsuyuguchi et
al. . 1990).

However, treatment of human monocytes with

gamma interferon decreased phagocytosis and had no
effect on the intracellular replication of EL. avium.
suggesting that gamma interferon does not have
macrophage-activating activity for IL avium infected
human monocytes (Toba et al.. 1989).

A group of

glycopeptidolipid surface antigens related to "mycoside
C" of the EL avium group have also been shown to be
inhibitory to phagocytes (Brennan, 1989).

A

glycolipid (polar GPL-1) isolated from M.
paratuberculosis by thin layer chromatography (TLC) has
been found to be antigenic and specific to the organism
(Camphausen et al.. 1985).
A 25 Kilodalton (Kd) glycolipoprotein from
Mycobacterium tuberculosis has been demonstrated that
inhibits the intracellular killing ability of
macrophages against Candida albicans and neutrophils
against Staphylococcus aureus (Wadee gt al.. 1987).
This inhibitory effect was reversed by the addition of
gamma interferon (Wadee gt al.. 1987).

This 25 Kd

glycolipoprotein has also been shown to inhibit hexose
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monophosphate shunt activity, lysozyme release, and
H202 production which are also reversible by the
addition of gamma interferon (Wadee gt al.. 1989).
Sulfolipid I isolated from IL tuberculosis has
been shown to be taken up in significant amounts by
human neutrophils and in lesser amounts by monocytes
and lymphocytes (Middlebrook, 1959).

Superoxide

production by these neutrophils was augmented at low to
moderate concentrations (<27 fig/ml), while higher
concentrations resulted in significant depression of
02‘ production.

This effect was prevented if the

monocytes were pretreated with gamma interferon
(Takayama and Armstrong, 1976).

A sulfatide present on

the outer surface of HL. tuberculosis was shown to
inhibit macrophage priming (Pabst et al.. 1988).
Sulfolipids may also promote bacterial virulence by
enhancing the toxicity of "cord factor" (trehalose
6,6'-dimycolate) (Goren et al.. 1974).
Cord factor has both immunostimulant and toxic
properties (Goren gt al.. 1974).

Cord factor is found

in a variety of bacteria including the mycobacteria,
corynebacteria and nocardia with virulent strains
typically possessing larger amounts (Petit and Lederer,
1984; Silva and Faccioli, 1988).

Cord factor induces

the production of tumor necrosis factor in mice
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resulting in cachexia and eventually death (Silva and
Faccioli, 1988).
Four mycobacterial cell wall lipids have been
tested for their effects on phospholipidic liposome
organization, passive permeability and oxidative
phosphorylation of isolated mitochondria (Sut et al..
1990).

It was concluded that the trehalose containing

lipids (dimycoloyltrehalose and polyphthienoyltrehalose) rigidified the fluid state of liposomes,
where triglycosyl phenolphthiocerol slightly fluidized
the gel state and peptidoglycolipid (apolar mycoside C)
shifted the phase transition temperature upward.
Dimycoloyltrehalose did not affect liposome passive
permeability; whereas, triglycosyl phenolphthiocerol
slightly decreased leaks and mycoside C greatly
increased leaks.

Both trehalose containing lipids

demonstrated inhibitory activity on oxidative
phosphorylation of mitochondria, while triglucosyl
phenolphthiocerol was inactive and mycoside C was very
active (Sut et al.f 1990).
As described above, there are many compounds
produced by mycobacteria that have been shown to
inhibit lymphocyte proliferation or to inhibit
phagocyte function thereby enabling the organism to
survive and multiply within the macrophage.

Many of
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these compounds are structural components of the
mycobacterial cell wall (Brennan, 1989).

The

mechanisms by which these compounds act are not known.
To this end, future research must be aimed at
isolating, characterizing and then modulating the
effects of these compounds.

Objectives

The exact mechanism by which Mycobacterium
paratuberculosis is able to survive and replicate
within bovine macrophages is as yet unknown.

The host

macrophage-bacterium interactions are highly complex
and difficult to determine.

The mechanism must be

related, at least to some degree, to the inhibition of
lymphocyte proliferation and of macrophage functions
caused by solubilized components or secretions of the
organism.

Several biologically active compounds have

been isolated and characterized from JL. tuberculosis.
M. bovis. JL. leprae and the £L. ayjMmdlntiaSBllBlaKfi
complex that have not been found in JL. paratuberculosis
(i.e. PGL-I).

Lipoarabinomannan, a compound ubiquitous

in mycobacteria, is found in !L_ paratuberculosis.
However, there are non-pathogenic species of
mycobacteria that also contain LAM.

This suggests that

although LAM probably plays a role, it is not the only
factor involved.

The lesions observed in

paratuberculosis are unique within mycobacterial
infections with only fL. avium infections being similar
If these immunosuppressive and macrophage inhibitory
compounds can be isolated and their mechanisms
elucidated, effective prophylactic regimens and
treatments may be developed to control this disease.

The objectives of this study were:

1.

To develop the methodology necessary for the

efficient lysis and fractionation of Mycobacterium
paratuberculosis.

2.

To isolate via fractionation of Mycobacterium

paratuberculosis fractions that demonstrate inhibition
of bovine macrophage-killing ability.

3.

To purify, wherever possible, the macrophage-

inhibitory compounds.

4.

To characterize and/or identify, wherever possible

the compound/s responsible for the macrophageinhibitory activity.
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ABSTRACT

Fractions from Mycobacterium paratuberculosis
(MPARA) strain 18 which exhibit activity detrimental to
the killing function of activated bovine monocyte/
macrophages (M<p) towards Candida albicans (CA) were
obtained .

Active fractions were derived by

ultrasonication of bacterial samples followed by
ammonium sulfate precipitation, ion-exchange
chromatography, gel filtration chromatography, heat
precipitation, acid precipitation and alkali treatment
with visualization by SDS-PAGE.

Two different

fractions that exhibited marked inhibition of M<p
killing ability were derived from MPARA and were
partially characterized.
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INTRODUCTION

Bovine paratuberculosis is a chronic,
debilitating, granulomatous, enteric disease caused by
infection with the acid-fast bacillus Mycobacterium
paratuberculosis (3).

Paratuberculosis is primarily a

disease of domestic ruminants occurring throughout the
world; however, numerous species of wildlife (2, 9, 33,
28) and monogastric domestic animals (13, 14, 19) have
been naturally or experimentally infected.
Mycobacterium paratuberculosis has been implicated
as a human pathogen.

A mycobacterial species with

morphological features and growth characteristics
identical to MPARA, which by DNA probe analysis is
identical to MPARA strain 19698, has been isolated from
non-AIDS infected human patients with Crohn's Disease
(4, 5, 6, 15, 16).

A close antigenic relationship

between MPARA and ML avium surface glycopeptidolipids
has been noted (1).

Comparisons of various

mycobacterial species by DNA probe analysis has shown
that MPARA strain 18 is identical to JL. avjium serovar
2X (17).
In the United States, it has been estimated that
the prevalence of infection is between 5% and 20% and
that the losses to the dairy industry alone exceed $1.5
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billion per year (3).

In Louisiana, a recent survey in

beef cattle herds revealed that 4.4% of the animals
tested and 30% of the herds tested were seropositive on
the ELIZA test with an estimated annual loss to the
Louisiana beef industry of $ 2,003,710.00 (29).
Usually a high number of organisms are passed in
the feces of infected animals and carriers which serve
as the primary source of infection for neonatal animals
(14).

After ingestion, the organism penetrates the

intestinal mucosa and is phagocytized by macrophages
(3).

The organism somehow is protected intracellularly

within the macrophages against humoral and cellular
defense mechanisms (18).

An intermittent, profuse,

chronic, diarrhea ensues as a result of a multifocal,
eventually generalized, chronic, progressive,
granulomatous, enteritis and lymphadenitis.

Bacteremia

and anergy occur in the terminal stages of MPARA
infections (3).
Currently, no research has addressed the
possibility of the production of a substance by MPARA
that inhibits the killing function of bovine M<p.

This

is an active area of research with 1L. tuberculosis (30,
31) and |L_ leprae (20, 21, 22, 10).

Recent research

has demonstrated a 25 Kd glycolipoprotein fraction from
Mycobacterium tuberculosis that was shown to inhibit

the intracellular killing of Candida albicans by
macrophages and Staphylococcus aureus by neutrophils
(30, 31).

This inhibitory effect was reversed by the

addition of r interferon.

Mycobacterial derived

lipoarabinomanan (LAM) has been shown to inhibit rinterferon-raediated activation of normal macrophages
(22).

Macrophages heavily burdened with 1L. leprae are

refractory to activation by r-interferon; whereas,
macrophages containing only a few JL. leprae are
activated (20, 10).
Clarification of the intracellular survival
mechanisms of MPARA may provide information that would
contribute to the understanding, prevention and
treatment of related human mycobacterial diseases such
as leprosy, tuberculosis, non-tuberculous AIDS related
mycobacterial infections and possibly Crohn's Disease
(Regional Ileitis).

The clarification of MPARA's

interaction with host cells as mediated by pathogenproduced inhibitory factors is expected to have broad
application to veterinary and human mycobacterial
diseases.
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MATERIALS AND METHODS

General
Bacterial cultures were obtained commercially (M.
paratuberculosis strain 18 from ATCC, Rockville, MD).
M. paratuberculosis

was grown in Middlebrooks 7H9

Broth (Difco Labs, Detroit, MI) supplemented with 100
ml/L Middlebrooks OADC Supplement (Difco Labs, Detroit,
MI) and 2.0 mg Mycobactin J (Allied Labs, Glenwood
Springs, CO) at 37° C for 21 days prior to harvest.
Bacterial cells were harvested by centrifugation (5,000
x g for 10 minutes) and washed twice with Standard
Buffer (20 mM Tris-HCl, 1.0 mM MgCl2 [pH = 7.5]).
All standard compounds and solvents were obtained
from commercial sources (Sigma Chemical, St. Louis, MO)
and were of the highest purity available.

Water for

dialysis, SDS-PAGE buffers and solutions was triple
distilled water polished by a Modulab Polisher I
(Continental Water Systems Corp., San Antonio, TX)
water purification system.

Spectrophotoraetric

determinations were performed on a Lambda 3A
spectrophotometer (Perkin Elmer Corp., Norwalk, CT).
Protein estimations were made spectrophotometrically
using the technique of Warburg and Christian (32).
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Sample Preparation
Samples of 2.0 - 5.0 gm (pelleted wet weight) of
MPARA were obtained from frozen cultures and
resuspended in 10 ml of Standard buffer (SB) (20 mM
Tris, ImM MgCl2 , pH 7.5).

Cells were disrupted by

ultrasonication at maximum power utilizing a
W-375 Sonicator Cell Disruptor (Heat SystemsUltrasonics, Inc., Plainview, NY) for a total of 20
minutes of continuous power using 2 minute on and 1
minute off cycles in an ice-water bath.
was not allowed to exceed 45°C.

Temperature

Precipitates were

pelleted in a Sorvall high speed centrifuge at 10,000 x
g, 4 °C for 40 minutes using polyallomer tubes and a
SS-34 rotor.

Cell lysates were subjected to ammonium

sulfate (AS) precipitation at concentrations of 25%,
50% and 75% (7, 27).

Precipitates were pelleted in a

Sorvall high speed centrifuge at 10,000 x g, 4 °C for
15 minutes using polyallomer tubes and a SS-34 rotor.
The 25%, 50% and the 75% precipitates were resuspended
in 2 ml SB per gm of bacteria used and desalted by
dialysis overnight against 2 changes of SB (4L each)
utilizing 12,000 - 14,000 molecular weight (MW) cutoff
cellulose dialysis tubing at 4°C (7, 27).

Samples were

concentrated by lyophilization, resuspended in 2.0 ml
H20 and tested in the M<p-CA killing assay.
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All four fractions were subjected to ion-exchange
column chromatography utilizing diethylaminoethyl
(DEAE) cellulose (Biorad, Rockville Center, NY) packed
in 15ml plastic econocolumns with column bed volumes of
10.0 ml using gravity flow adjusted to approximately
1.0 ml per minute.

The column was sequentially eluted

in step fashion with 10.0 ml each of 0.1M, 0.2M, 0.3M,
0.4M, 0.5M, 0.6M and 1.0M NaCl solutions (7, 27).
Samples were desalted by dialysis overnight against 2
changes of SB (4L each) utilizing 12,000 - 14,000 MW
cutoff cellulose dialysis tubing at 4°C.

Samples were

concentrated by lyophilization, resuspended in 2.0 ml
H20 and tested in the M<p-CA killing assay.
An active fraction (25-50% AS 0.2M NaCl
DEAE)(1.0ml) was heated to 100°C for 15 minutes to
assess heat stability.

To determine acid and alkali

stability, a similar amount was titrated to pH 4.5 by
the addition of IN HC1 (3.0 fil) and allowed to sit at
room temperature (RT) for 30 minutes, then centrifuged
at 10,000 x g for 10 minutes at 4°C in Eppendorf
microcentrifuge.

The supernate was transferred to a

new 1.5 ml microcentrifuge tube and the pellet was
washed in 1.0 ml SB (pH 7.5).

After centrifugation at

10.000 x g for 5 minutes at 4°C the pellet and
supernate were separated and the pellet resuspended in
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1.0 ml SB (pH 9.5) to test alkali stability, then
heated to 100°C for 1 hour.

The pellet sample was then

centrifuged at 10,000 x g at 4°C for 5 minutes and
supernate and pellet separated.

All samples were

adjusted to pH 7.5 with IN NaOH prior to testing in the
M<p-CA killing assay (modified from Sigurdsson) (23, 24,
25, 26).
Active fractions (25-50% AS 0.2M, 0.3M, 0.4M NaCl
DEAE fractions) were pooled (1.5ml each), incubated at
100°C for 20 minutes, centrifuged at 10,000 x g in an
Eppendorf microcentrifuge and the supernate was
lyophilized and resuspended in 2.0 ml H20.

This sample

was subjected to gel filtration chromatography
utilizing a 1.0cm x 45cm glass Econocolumn (Biorad,
Rockville Center, NY) packed with Sephacryl HR-200
(Pharmacia LKB Biotechnology, Piscataway, NJ) and SB
(pH 7.5).

Column flow was by gravity from a 500 ml

Marriot flask adjusted to a flow rate of approximately
1.0 ml per minute (VQ [13.5 ml] and

[29.5] were

determined using 1.0% blue dextran and 10% copper
sulfate) with 2.0 ml samples collected (7, 27).

Macrophage - C^_ albicans Killing Assay.
Bovine peripheral blood mononuclear cells (PBMC)
were obtained from peripheral blood by Ficoll-Hypaque
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density gradient centrifugation using Histopaque 1083
(Sigma).

An equal volume of whole blood was layered

gently on 20 ml of Histopaque 1083 in 50ml clear
polycarbonate centrifuge tubes.

Samples are

centrifuged at 450 x g for 45 minutes at 4°C.

The

resultant band containing PBMC's was removed by
aspiration with a long sterile Pasteur pipette and
transferred to a fresh centrifuge tube containing
approximately 30ml phosphate buffered saline pH 7.5
(PBS).

Cells were mixed by pipetting multiple times.

The sample was centrifuged as before for 10 minutes,
the supernate was discarded and the cell pellet was
resuspended by pipetting with 10ml of PBS for a total
of three washes.

PBMC were resuspended in RPMI

buffered with sodium bicarbonate containing lOOng/ml E.
coli lipopolysaccharide (LPS), lOOng/ml phorbol
myristate acetate (PMA) per ml, 100/xg ampicillin and
100/ig/ml streptomycin (Sigma) to a final concentration
of approximately 50,000 M<p per 300/Ltl.

The percentage

of Mip was determined by white blood cell differential
count with confirmation by non-specific esterase
staining (11). PBMC solution (300/il) was added to the
wells of a 96 well plastic tissue culture plate and
allowed to incubate for 16 hours at 37°C with 5% C02 Wells were then washed three times with 300/zl of fresh
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media to remove the lymphocytes and allowed to incubate
at similar parameters for 8 hours.
Aliquots (25/xl) of each fraction collected and
approximately 10,000 Candida albicans cultured
overnight (24 hours) in modified Winge media (.2%
glucose and .3% yeast extract) containing lOOug
Ampicillin and lOOug Streptomycin per ml diluted in
200ul of RPMI 1640 buffered with sodium bicarbonate
containing lOOug Ampicillin and lOOug Streptomycin were
simultaneously added to each well and incubated for 16
hours at 37°C with 5% C02-

A 5.0ml 24 hour culture of

CA averaged approximately 2.0 x 108 colony forming
units (CFU) CA.

All samples were tested in triplicate.

Viability of M<p was assessed by exclusion of trypan
blue and viability was consistently greater than 90%.
Plates were centrifuged at 450 x g for 10 minutes at
4°C and the supernate discarded.

A 0.02% sodium

dodecyl-sulfate aqueous solution (300^1) was added to
each well to lyse the M<p and the pellet was resuspended
by mixing and pipetting (25 times) using a 100/*1
pipetteman.

Contents of each well was transferred to a

1.5ml microcentrifuge tube after at least 1 hour of
incubation at RT and vortexed vigorously.

Dilutions of

102 and 103 were prepared in 1.5ml microcentrifuge
tubes using sterile H20 as the diluent.

Aliquots
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(50/il) of each dilution were plated using a bent
Pasteur pipette on 60mm x 15mm culture plates
containing Sabaroud's Dextrose media (Difco).

After 24

hours incubation at 37°C, CFU of CA are enumerated
(modified from Decker et. a l . 1986) (8).

Statistical

analysis (Tukey's Studentized Range Test) of the
obtained CFU was done to analyze the activity of
suspected active fractions versus control CFU.

SDS—PAGE
Molecular weight standards for SDS-PAGE were
commercially obtained (Low molecular weight
electrophoresis calibration kit, Pharmacia LKB
Biotechnology, Piscataway, NJ).

Electrophoresis was

performed with a model V16 vertical electrophoresis
system (BRL, Gathersburg, MD) and model EC-103 power
source (E-C Apparatus Corp., St. Petersburg, FL).
Electrophoresis was performed using a 4.5% stacking gel
and a 12.0% separating gel (pH 6.6 and 8.8,
respectively) (12).

Aliquots of each sample

(100-

200/il were lyophilized or precipitated in acetone, then
solubilized by heating for 3 minutes at 100°C

in30 nl

sample buffer (10% glycerol, 2% SDS, 5% 2mercaptoethanol, 0.125 Tris-HCl [pH 6.8] and 0.01%
Bromophenol blue).

Gels were run at constant current
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of approximately 30 mA in the stack and separating
gels.

Electrophoresis was continued until the tracking

dye was approximately 1.0 cm from the bottom of the gel
(approximately 5.0 hours).
stained primarily

Polyacrylamide gels were

with silver using the technique of

Wray et. al. (34). Apparent molecular weights were
determined by comparison with standards of known
molecular weight:

Phosphorylase B 94 kilodaltons (Kd),

Albumin 67 Kd, Ovalbumin 43 Kd, Carbonic Anhydrase 30
Kd, Trypsin Inhibitor 20.1 Kd and a-Lactalbumin 14.4
Kd.
RESULTS

Fractions derived from MPARA exhibiting CFU of CA
greater than four times the mean SD (standard
deviation) of the negative control (PBS) were selected
for further analysis.

The initial fractions meeting

this criteria were 25-50% AS, 25-50% AS 0.2M NaCl DEAE,
25-50% AS 0.3M NaCl DEAE, 25-50% AS 0.4M NaCl DEAE and
25-50% AS 0.5M NaCl DEAE.

Similar activity was found

in the 50-75% AS fraction; however, no such activity
was observed in the subsequent DEAE fractions.
An active fraction (25-50% AS 0.2M NaCl DEAE) was
found to be heat, acid and alkali stable.

All

fractions of each treatment exhibited no appreciable
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loss of activity (Table 1).

Subsequent heat treatment

at 100°C for 30 minutes also resulted in no loss of
activity (data not shown).
The active fractions 25-50% AS 0.2M NaCl DEAE, 2550% AS 0.3H NaCl DEAE, 25-50% AS 0.4M NaCl DEAE and 2550% AS 0.5M NaCl DEAE were pooled and subjected to
Sephacryl HR-200 gel filtration.

The elution profile

of the proteins in this sample is presented in Figure
1.

Two fractions derived from the 25-50% AS 0.2M-0.5M

NaCl DEAE Heat treated fraction (HR-200 #1 & #2 and HR200 #5 & #6) demonstrated M<p inhibitory activity (Table
2).

SDS-PAGE of the Sephacryl HR-200 derived fractions

is presented in Figure 2.

Lanes 1 & 2 (HR-200 #1 &

#2) exhibited small higher molecular weight bands (50 100 Kd) and three large overlaping bands at 25 - 27 Kd.
Lane 5 (HR-200 #5) exhibited a prominent band at
approximately

24 - 25 Kilodaltons (Kd) along with

other very faint bands and lane 6 (HR-200 #6) also
contained a similar but less dense band.

DISCUSSION

Various fractions were derived from MPARA strain
18 by ultrasonication of bacterial samples followed by
ammonium sulfate precipitation, ion-exchange
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chromatography, gel filtration chromatography, heat
precipitation, acid precipitation and alkali treatment.
After dialysis, all fractions obtained by AS
precipitation and DEAE ion-exchange chromatography were
screened initially without replicates in the M<p-CA
inhibition of killing assay and compared to negative
controls.

Fractions exhibiting CFU of CA greater than

four times the mean SD (standard deviation) of the
negative control (PBS) were selected for further
verification of activity.

The initial fractions

meeting this criteria were 25-50% AS, 25-50% AS 0.2M
NaCl DEAE, 25-50% AS 0.3M NaCl DEAE, 25-50% AS 0.4M
NaCl DEAE and 25-50% AS 0.5M NaCl DEAE.

Similar

activity was found in the 50-75% AS fraction; however,
no such activity was observed in the subsequent DEAE
fractions, which suggests that the activity in the 5075% AS fraction was probably carry over from the 25-50%
AS fraction.

A repeat of the initial screen produced

similar results.
All treatments of the 25-50% AS 0.2M NaCl DEAE
fraction exhibited no appreciable loss of activity,
suggesting that the inhibitory factor is heat stable
(100°C), acid stable (pH 4.5) and alkali stable (pH
9.5).

This suggests that the M<p-inhibitory factor/s

are either highly stable proteins or more likely
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combinations of lipid and carbohydrate. The SDS-PAGE
gel (Figure 2) of the HR-200 fractions suggests an
alteration in mobility in the 25 - 27 Kd bands in the
lane 1 (HR-200 #1) and suggests they are probably not
strictly protein in nature.

This is probable since one

would expect only higher molecular weight species to
elute in this fraction from a gel filtration column.
Also note that lanes 3 and 4 (HR-200

#3

&

# 4 )

contain

low molecular weight species that would not normally be
expected to elute so quickly.

These bands that do not

follow the expected pattern are probably glycoproteins
and/or peptidoglycolipids, which may account for their
altered mobility on the SDS-PAGE gel.

Although

highly speculative, the gel suggests that the
inhibitory activity of the compounds in lane 1 may be
due to the 25 - 27 Kd bands and the activity of the
compounds in lane 5 may be due to the 24 - 25 Kd band.
At this stage of purification, at least two
macrophage inhibitory factors derived from MPARA, as
determined by testing of multiple fractions in a M<p-CA
killing assay were identified.

The data also suggest

that the factor/s are extremely heat stable, acid
stable and alkali stable and are probably some
combination of protein, lipid and carbohydrate (i.e.,
peptidoglycolipid, glycoprotein, glycolipid).

Further

characterization and elucidation of the structure and
mechanisms of action of these fractions is needed.

Table 1.

Stability of MPARA active fraction 25-50% AS

0.2M NaCl DEAE fraction to heat (100°C for 15 min),
acid (pH 4.5) and alkali (pH 9.5) as tested in M<p-CA
killing assay.

Fraction

CFU

Heat Tx.

160.0 +/-

Acid Tx. ^

153.0 +/- 26.98

Acid Tx. & Heat Tx.

231.3 +/“

4.62

5.03

Acid Tx., Alkali Tx. & Heat Tx. (a/b) 198.0 +/“ 38.03
Acid pellet wash (b)
Negative control (PBS) (c)

150.8 +/- 12.04
26.8 +/-

6.55

CFU CA reported as mean CFU at 103 dilution +/- SD
(n=4).

samples with different letters are

significantly different at p < 0.01.

51

Table 2.

M<p inhibitory activity of Sephacryl HR-200

derived fractions from heat treated (100°C for 20 min),
25-50% AS, 0.2M - 0.5H NaCl DEAE

fractions (no

replicates performed).

HR-200 fraction

CFU

HR-200 #1

15

HR-200 #2

14

HR-200 #3

3

HR-200 #4

7

HR-200 #5

18

HR-200 #6

13

HR-200 #7

10

HR-200 #8

10

HR-200 #9

3

HR-200 #10

10

HR-200 #11

9

25-50% AS 0.2M-0.5M DEAE, Heat Tx
Control. (PBS)*

CFU CA presented at 104 dilution.
* mean (n=2, SD=1.41)

23
5

H R -200 Protein Elution Profile
0.08

Protein mg/ml

0.07
0.06
0.05
0.04
0.03
0.02

-

0.01

0

2

4

6

8

10

12

HR-200 Fractions

Figure 1.

Protein elution profile of Heat treated, 25-

50% AS 0.2M-0.5H NaCl DEAE pooled fractions after
subjected to Sephacryl HR-200 gel filtration.

Figure 2.

SDS-PAGE analysis of Sephacryl HR-200

fractions from heat treated, 25-50% AS 0.2M-0.5M NaCl
DEAE pooled fractions.

(A) 25-50% AS 0.2M-0.5M DEAE

pooled fraction; ( 1 - 6 ) HR-200 #1 - #6 samples
respectively.
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ABSTRACT
A novel method for the lysis and subsequent
fractionation of bacterial constituents from
Mycobacterium Daratuberculosis strain 18 (|L_
paratuberculosis) and JL-. coli strain DH5a utilizing the
technique of matrix solid-phase dispersion (MSPD) is
described.

Bacteria were blended with octadecylsilyl
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(Clg) derivatized silica to obtain cellular lysis. The
blended material was used to prepare a column which was
sequentially eluted with solvents of increasing
polarity.

Fractionation of cellular components was

confirmed by analysis of the solvent extracts.

The

possible applicability of the MSPD technique as a
general method for the lysis and fractionation of
bacterial components is proposed.

INTRODUCTION

The lysis of bacterial cells and the subsequent
isolation and purification of various compounds from
disrupted bacteria is often a complex and laborious
task.

For animal cells, relatively mild procedures

will accomplish cell lysis.

However, the presence of

cell walls, as occurs in plants, bacteria and fungi,
often requires procedures that are chemically and
physically harsh in order to obtain complete cellular
disruption.

Classical methods for performing lysis of

bacterial cells have involved the utilization of enzyme
treatments to weaken the cell wall, grinding of the
cells in the presence of abrasives, sonication or
extrusion by means of presses.

Following lysis, one

may further disrupt the membrane fragments and
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subcellular structures that are obtained by the
inclusion of surfactants in the procedure.

This

process assists in the solubilization of cell
membranes, proteins and other cell components,
enhancing the subsequent recovery and isolation of
these compounds.

However, the detergents themselves

often complicate or interfere with the isolation or
fractionation of target molecules and often require
additional steps to assure their removal (1).
Fractionation of lysates usually involves
techniques that are often highly specialized for the
efficient isolation of the compound of interest
protein, lipid, carbohydrate, etc.).

(i.e.,

These techniques

may involve centrifugation, repeated solvent
extractions, salt fractionation, gradient
fractionation, ion-exchange chromatography, gel
permeation chromatography, thin layer chromatography,
high pressure liquid chromatography (HPLC) or some
combination of these and other techniques.

These

protocols often require a variety of reagents, a high
degree of sample manipulation and a considerable amount
of time to perform (1,2).

Furthermore, the yields

obtained for the compounds of interest are often low
due to losses that occur from the harsh nature or
complexity of many such treatments.
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The bacterium, 3L_ coli. can be readily disrupted
by treatment with lysozyme and low concentrations of
sodium dodecyl-sulfate (SDS) (3) or short bursts of
sonication.

Mycobacteria, such as Mycobacterium

paratuberculosis. require more severe procedures for
complete cellular disruption, such as treatment with
antibiotics (ampicillin and D-cycloserine) and high
concentrations of SDS or extended sonication (20
minutes at maximum capacity) (4,5).

Indeed,

mycobacteria are some of the most difficult bacteria to
disrupt due to the thickness of their cell walls.
Presented here is a new approach, called matrix
solid phase dispersion (MSPD), for the complete lysis
and subsequent fractionation of bacteria that
eliminates many of the aforementioned difficulties
associated with classical methods of disruption and
fractionation that can be accomplished in minutes.
This one step approach is chemically and physically
mild, employing the use of a lipophilic polymer ^C18 ^
bound to a solid support (silica) to lyse and disperse
cellular components and to produce a semi-dry, easy to
handle column packing material from which various
bacterial constituents can be sequentially eluted from
a single sample using small volumes of solvents (6,7).
In this report, the first application of this

67

methodology for the lysis and fractionation of
Mycobacterium paratuberculosis strain 18 and iL. coli
strain DH5a is presented.

MATERIALS AND METHODS
Column Preparation

Bulk C18 (22 gm, 40 fim, 18% load, end-capped,
octadecylsilyl -derivatized silica, Analytichem Int.,
Harbor City, CA) was placed in a column (50 ml syringe
barrel) and sequentially washed with two column volumes
each of hexane (HX), methylene chloride (DCM), and
methanol (MeOH) by vacuum aspiration until dry to
remove contaminants inherent in manufacture. Syringe
barrels (10 m l ), which were used to prepare elution
columns for samples, were thoroughly washed and dried
prior to use.

Filter paper discs (1.5 cm, Whatman No.

1) were used as retainers for the C18 material within
elution columns.

A 100 pi disposable pipette tip

trimmed to fit the syringe tip was used to slow the
column flow rate. Triplicate bacterial samples of 0.5
gm were uniformly blended with C18 (1L. paratuberculosis
- 3.0 gm, £*. coli - 2.0 gm) in a mortar and pestle and
transferred to columns as prepared above (total
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blending time approximately 30 seconds).

The material

was packed into the column using a syringe plunger and
a 1.5 cm Whatman No. 1 filter was placed on top as a
retainer.
Bacterial cultures were obtained commercially (H.
paratuberculosis from ATCC, Rockville, HD and £_*. coli
from BRL, Gathersburg, HD).

JL. paratuberculosis was

grown in Hiddlebrooks 7H9 Broth (Difco Labs, Detroit,
HI) supplemented with 100 ml/1 Hiddlebrooks OADC
Supplement (Difco Labs, Detroit, HI) and 2.0 mg
Hycobactin J (Allied Labs, Glenwood Springs, CO) at 37°
C for 21 days prior to harvest.

coli was grown in

Luria Bertani media (10 gm Bactotryptone (Difco), 5.0
gm Yeast extract (Difco), 10 gm NaCl, pH 7.4) at 37° C
for 24 hours prior to harvest.

Bacterial cells were

harvested by centrifugation (10,000X G for 10 minutes)
and washed twice with Standard Buffer (20 mH Tris-HCl,
2.0 rnH HgCl2 [pH = 7.5]).
All standard compounds and solvents were obtained
from commercial sources (Sigma Chemical and Fisher
Chemical) and were of the highest purity available.
Water for extraction, SDS-PAGE buffers and HPLC
analysis was triple distilled water polished by a
Hodulab Polisher I (Continental Water Systems Corp.,
San Antonio, TX) water purification system.
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Spectrophotometric determinations were performed on a
Lambda 3A spectrophotometer (Perkin Elmer Corp.,
Norwalk, CT).

Scanning Electron Microscopy

Samples of pelleted !L_ paratuberculosis and
coli (0.5 gm wet weight of each) were blended with 3.0
gm and 2.0 gm Clg material respectively, in a mortar
and pestle as previously described.

A sample of M.

paratuberculosis (0.5 gm) also was blended with
underivatized silica (40 pm, 18% load, end capped,
silica without Clg polymer) as a positive control.
Silica (no Clg polymer) and Clg material without
bacteria were used as negative controls.

Scanning

Electron Microscopy (SEM) mounts (aluminum) were coated
with a thin layer of graphite paint.

A small aliquot

of blended material was sprinkled onto the SEM mount
and was allowed to stick to the wet graphite paint.
After drying (overnight) the excess material was
removed by abrupt shaking.

The coated SEM mount was

then shadowed with gold-palladium and viewed with a
Cambridge Stereoscan model F-150 Scanning Electron
Microscope.
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Mass. Balance Determination

Triplicate samples of H a paratuberculosis (0.5 gm
each) were prepared as described previously using the
MSPD technique.

Appropriate volumes of HX, DCM,

Acetonitrile (ACN), MeOH and H20 (12.0 ml) were poured
into the column and allowed to filter through the
column by gravity flow.

Retained solvent was removed

from the column using air pressure generated by a
pipette bulb.

Solvent fractions were collected in

either 10 ml glass cone-bottomed tubes or 15 ml
polypropylene cone-bottomed tubes with screw caps.

The

HX, DCM, ACN and MeOH fractions were evaporated to
dryness under dry nitrogen.
lyophilized to dryness.

Water extracts were

All samples (after drying),

C18 material and glassware were weighed before and
after fractionation using a H31AR Mettler mechanical
balance that had been professionally calibrated within
30 days.

Drying of pelleted bacteria to obtain dry

weight and used c18 material was accomplished at 100° C
for 24 hours using a heat convection oven.

Blanks

consisted of 12.0 mis each of HX, DCM, ACN, MeOH and
H20 passed through prepared MSPD syringe columns
without C18 material or bacteria

and a similar volume

of each solvent passed through prepared MSPD syringe
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columns with Clg material and no bacteria.

EJLQtg.jp.

Quantitation

The presence and quantity of protein was
determined using the Markwell method.

The Harkwell

method is a modification of the Lowry technique that
allows for the rapid assay of membrane and lipoprotein
preparations or samples containing sucrose or EDTA.
The modification of the original Lowry technique, by
adding 1.0% SDS to the alkali reagent, allows the rapid
solubilization

of lipoproteins instead of the usual

time consuming process of delipidation.

A 4.0%

solution of copper sulfate is added to the SDS
containing alkali reagent to form an alkaline copper
reagent, which is then added to the sample.

After

incubation at room temperature for 10 to 60 minutes,
diluted Folin-Ciocalteu reagent is added, mixed
vigorously and incubated for 45 minutes at room
temperature.

Absorbance is read at 660 nm (10).

Molecular weight standards for SDS-PAGE were
commercially obtained (Low molecular weight
electrophoresis calibration kit, Pharmacia LKB
Biotechnology, Piscataway, NJ).

Electrophoresis was

performed with a model V16 vertical electrophoresis
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system (BRL, Gathersburg, MD) and model EC-103 power
source (E-C Apparatus Corp., St. Petersburg, FL).
Electrophoresis was performed in triplicate for each
bacterium using a 4.5% stacking gel and a 12.0%
separating gel (pH 6.6 and 8.8, respectively) (9).
Water extracts of each MSPD fraction (Silver stained
gels [10 - 40 ng] and Coomassie stained gels [1.0 - 20
fig]) were lyophilized then solubilized by heating for 3
minutes at 100°C in 30 fil sample buffer (10% glycerol,
2% SDS, 5% 2-mercaptoethanol, 0.125 Tris-HCl [pH 6.8]
and 0.01% Bromophenol blue).

Gels were run at constant

current of approximately 30 mA in the stack and
separating gels.

Electrophoresis was continued until

the tracking dye was approximately 1.0 cm from the
bottom of the gel (approximately 5.0 hours).
Polyacrylamide gels were stained primarily

with silver

using the technique of Wray et. al. (12) or with R-255
Coomassie Brilliant Blue (Sigma Chemical, St. Louis,
MO) for confirmation (1). Apparent molecular weights
were determined by comparison with standards of known
molecular weight:

Phosphorylase B 94 kilodaltons (Kd),

Albumin 67 Kd, Ovalbumin 43 Kd, Carbonic Anhydrase 30
Kd, Trypsin Inhibitor 20.1 Kd and a-Lactalbumin 14.4
Kd.
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Gas Chromatorgraphy/Mass Spectroscopy

Gas Chromatography/Mass Spectroscopic (GC/MS)
analyses were conducted using a model 5970 GC/MS
(Hewlett-Packard, MSD, Camas, WA) with tuning file
parameters of 70 eV, 2200 emV, 2 second/mass decade
scan and method file parameters of 50° C to 300° C per
run, hold 1 min. at 50° C, rising 3° C per minute, hold
9 min. at 300° C for an 18 min. total run.

Analyses

were conducted in the splitless mode with the purge
function being initiated at 0.5 min. post injection.
Acylglycerol lipids as total fatty acid methylesters
(FAME) were determined by direct extraction /
derivatization from samples using 0.4N methanolic
sodium methoxide in hexane solution (17).

Sugars,

amino acids, purines, pyrimidines, etc. were determined
by direct trimethylsilyl (TMS) derivatization of MSPD
fractions using N,o-bis (Trimethylsilyl)
trifluoroacetamide (BSTFA) in hexane solution (18).

Other Analyses

High Pressure Liquid Chromatographic (HPLC)
analyses was performed using a Hewlett-Packard HP 1090
(HP79994 HPLC Chemstation) liquid chromatograph
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(Hewlett-Packard, Camas, WA) equipped with a photodiode
array detector (UV 220 run, 260 run and 280 nm, 20 nm
bandwidth, 0.1 mAUPS, reference spectrum range 200-450
nm).

The solvent system was an ACN/H20 gradient (100%

H20 for 10 min., gradient to 95% ACN - 5% H20 by 40
min., hold for 10 min.) at a flow rate of 1.0 ml/min.
The HPLC data were analyzed as to peak retention time
only.

Peaks present in blanks (no bacteria) were

subtracted from sample peak retention times.
The presence of nucleic acids was determined
spectrophotometrically by absorbance at 260 nm and by
the presence of fluorescent bands on a 1.0% agarose
mini-gel after staining with ethidium bromide (EtBr).
The quality of the nucleic acid preparation was
determined using the OD 260/280 ratio and the quantity
was determined using the OD 260 (23).
The presence of phospholipids was determined by a
direct colorimetric method utilizing Dithiocyanatoiron
reagent (0.97 gm ferric nitrate, 15.2 gm ammonium
thiocyanate, q.s. to 100 ml H20) measured at 470 nm

(22 ).
Quantitation of

coli lipopolysaccharide (LPS)

was performed using standards were prepared from a
known concentration of SL. coli LPS (Sigma Chemical, St.
Louis, MO) for preparation of the standard curve.
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Samples (lOOjul) from each E_i_ coli extract resuspended
in H20 were tested in the 2-keto-3-deoxyoctonic acid
(KDO) assay.

The method involves the treatment of LPS

with 0.2 N H2S04 at 100°C for 30 minutes to release the
KDO, followed by its reaction with periodic acid,
sodiun arsenate and thiobarbituric acid.
Dimethylsulfoxide was added to form a red color.
Samples and standards were read at ABS 548 against the
blank (24).

Sample concentrations were calculated by

linear regression.

RESULTS AND DISCUSSION

gjg.l.l_ular Lvsis

Samples of JL. paratuberculosis and

coli (0.5

gm) were blended with octadecylsilyl (C18)-derivatized
silica using a mortar and pestle and the resulting
blend was packed into a syringe barrel (10 ml)
chromatography column (6,7).

A portion of each blend

was prepared for scanning electron microscopy (SEM) to
determine the role of the covalently bound lipophilic
polymer versus the mechanical and hydrophilic
properties of 40 fiia silica particles.

A negative

control consisting of C18 derivatized silica with no

76

bacteria added, demonstrates the appearance of the C18
particles alone (Figure 1A).

A positive control

consisting of underivatized silica packing material (no
C18 polymer) and JL. paratuberculosis cells (Figure IB)
demonstrates the presence of clusters of fractured and
intact mycobacteria (arrows).

Figure 1C (C18 + JL.

paratuberculosis) and Figure ID (C18 + £*_ coli)
illustrate bacterial cell disruption and demonstrate
the relatively uniform dispersion of the bacterial
components onto the surface of individual particles
that we have routinely observed.

No evidence of intact

bacteria has been observed where bacteria and polymercoated particles have been blended.
It is proposed that the mechanisms for the process
of cell lysis and dispersion of the cellular components
occur by both mechanical and hydrophobic forces.
Grinding of cells with abrasives (silica or alumina
particles) has been used to lyse bacteria but does not
always result in complete disruption (see Figure IB).
Nevertheless, the serrated edges and irregular surfaces
of the silica particles (see Figure 1A) are capable of
producing

shearing forces that will generate a degree

of cellular disruption.

The MSPD technique includes

the presence of a lipophilic polymer (C18) covalently
bound to such an irregular shaped abrasive.

The
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material is also end-capped, with silicate functional
groups not initially derivatized by C18 in the
manufacturing process being sequentially converted to
silicate ethers, producing a highly lipophilic surface.
As utilized here, it is thought that the polymer
assists in the disruption process by solubilizing
membrane lipids.

This solubilization of the cell

membranes appears to result in a uniform dispersion of
bacterial constituents over the surface of the C18
derivatized particles.

Neutral lipids and

phospholipids would be expected to orient in the most
thermodynamically stable arrangement in relation to the
polymer phase and the more polar constituents released
during lysis.

Since the polymer is highly lipophilic,

it is unlikely that the membranes undergo vesiculation
during the disruption process.

The more polar

constituents are also expected to disperse to give the
most thermodynamically stable arrangement and probably
form clusters of hydrophilic material that associate
with the polar ends of the phospholipids and other
components which may be partially inserted into the
Clg/lipid matrix (8).

It is believed that this

arrangement gives the MSPD technique unique
chromatographic characteristics (6,7).
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Er.ag.tionation ol fia U alar components

This dispersion of materials forms a
polymer/tissue matrix assemblage on a solid support
that can be packed into a column and sequentially
eluted with solvents.
bacteria examined here,

At the ratios of C18 to pelleted
the material obtained after

blending is semi-dry and easily transferred to a column
housing for subsequent elution.

Due to the nature of

this dispersion, sequential elution of columns prepared
from these materials with solvents of increasing
polarity provide a sequential solubilization and
elution of compounds of like polarity.
Elution of MSPD columns in a reverse order of
polarity, beginning with water, tends to strip the
column of higher molecular weight, polar species (DNA,
etc.), further elution with methanol removes not only
polar species (sugars, etc.) but also phospholipids,
steroids and triglycerides.

Thus, the methods'

fractionation capabilities are diminished.

However, in

instances where high molecular weight polar species are
of interest, an initial fractionation of such compounds
from other cellular compounds can be obtained using
this approach (25).
As examined here, £L. paratuberculosis MSPD columns
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(triplicate) were eluted with hexane (HX), methylene
chloride (DCM), acetonitrile (ACN), methanol (MeOH) and
HPLC grade water (H20) and a mass balance determination
was performed.
Table 1.

Percent recoveries are summarized in

After subtraction of mass contributions from

the solvent and column controls (without C18), mass
balance calculations revealed a recovery of 99.97% (+/4.73%) with only 6.8% (+/- 0.5%) of the sample
remaining on the C18 material.
Analysis for various cellular constituents were
conducted on the various eluates to further demonstrate
that cellular lysis and fractionation had occurred.
Distribution of proteins in the 1L paratuberculosis and
E. coli MSPD samples was determined using sodium
dodecyl sulfate - polyacrylamide gel electrophoresis
(SDS-PAGE) (9) and a modified Lowry protein
determination procedure (Markwell) since some fractions
contained significant amounts of lipid and/or sugar
(10).

Attempts using the Quantigold Protein

Determination Kit (Diversified Biotech, Newton Center,
MA) and the Bio-Rad protein assay kit (Bio-Rad) (11)
were unsuccessful due to precipitation, presumably due
to interfering substances (lipid and/or sugar).
Markwell protein determinations are summarized in Table
2.

Figure 2A (M. paratuberculosis) and Figure 2B (E.
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coli) demonstrate the major protein bands observed in
each sample and correlate with the Markwell protein
determinations.

Note that the distribution of proteins

between the two bacteria are different; although, in
both cases the majority of protein appears in the H20
eluants.

Although there is an apparent discrepancy

between the amount of protein in the methanol extracts
of both organisms by Markwell protein determination and
visualization of protein bands by silver stained SDSPAGE gels, this discrepancy can be explained by the
presence of short peptides, glycoproteins and possibly
proteolipids that would stain poorly, if at all, with
protein specific silver staining.

This explanation is

supported by the presence of a number of peaks
identified by GC/MS as amino acids (Table 3) and silver
stains modified to enhance staining of carbohydrate
groups (data not shown) (26). Mycobacterium
paratubercu1osis exhibits significant amounts of
protein in the DCM extract and small amounts in the
MeOH extract whereas

coli exhibited small amounts of

protein in the ACN and MeOH extracts.

This is likely

due to differences in hydrophobicity of certain
mycobacterial vs. £_*. coli proteins and differences in
the interactions between the individual proteins and
the remaining constituents on the column.

The
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distribution of proteins suggests that the proteins
present in the more nonpolar solvents (DCM, ACN) may be
more lipophilic and possibly associated with cell
membranes in their native environment.

Although

extensive research has been conducted on the cell wall
proteins, lipids and carbohydrates of certain
mycobacteria (13), limited information is available
concerning those of &*. oaratuberculosis (14-16).
The distribution of lipids, carbohydrate, amino
acids, etc. was determined by derivatization of dried
sample extracts and evaluation by GC/MS.

Lipids as

total fatty acid methylesters (17) and trimethylsilyl
derivatives of carbohydrates, amino acids, etc. (18)
were determined on the HX, DCM, ACN and MeOH sample
extracts.

Data derived from GC/MS were analyzed using

a computerized database search utilizing the 8 peak
indexing system (19).

Attempts were made to interpret,

as to compound class, all unidentified spectra which
were consistent with library references using
guidelines promoted by McLafferty (20) and Beynon (22).
Spectra observed in blanks (no bacteria) were
subtracted from sample spectra.

Comparison with known

standards was accomplished when such standards were
available (fatty acid methyl esters).
of M-r. paratuberculosis and

The GC/MS data

coli are summarized in
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Table 3.

Note that after drying and treatment of the

samples with methanolic sodium methoxide, the M.
paratuberculosis HX, DCM and MeOH extracts contained
fatty acid

methyl esters (FAMES)ranging from 14 to

carbons inlength and in
extracts contained fatty
from 14 to

coli

24

the DCM and MeOH

acid methyl esters ranging

19 carbons in length.

No fatty acid methyl

esters were observed in the ACN extract of either
bacterium.

Each sample was examined for the presence

of phospholipids using a direct colorimetric method
utilizing dithiocyanatoiron reagent (22).

This

revealed the presence of significant quantities of
phospholipids only in H*. paratuberculosis DCM and MeOH
extracts and £*. coli MeOH extract and suggests that
phospholipids and neutral lipids can be separated by
this technique.

Likewise, fractionation of sterols,

indoles, polyols, amino acids, purines, pyrimidines,
inositols and other mono- and disaccharides was
observed for each of the bacteria (see Table 3).
Hexane, DCM, ACN, MeOH and H 20 extracts of M.
paratuberculosis and fL*. coli were further examined by
sonication with H20 followed by filtration and analysis
by HPLC (2) utilizing a photo-diode array detector and
recording absorbance (ABS) at several wavelengths.
Data derived by HPLC were analyzed as to retention
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times only and for purposes of comparison.

Many of the

peak retention times were different between each
solvent extract and each bacterium, thereby indicating
fractionation of bacterial constituents (Data not
shown).

The HPLC data also illustrated that a range of

compounds of distinguishable polarities were obtained
in each fraction and that there are similarities in the
occurrence of certain compounds between the two
bacterial species.

While the co-eluting compounds

isolated in each MSPD fraction would be expected to
have similar polarities, the reversed phase HPLC method
used in this analysis was able to provide wider
separation of the individual components.

This may

indicate that the separation efficiency of MSPD is
minimal or that the mechanisms involved in the
fractionation are not strictly those of reversed-phase
partitioning phenomena.
Mycobacterium paratuberculosis and fL*. coli solvent
extracts were further analyzed for the presence of
nucleic acids spectrophotometrically using the OD
260/280 ratio and a 1% agarose mini-gel stained with
ethidium bromide (23).

Escherichia coli strain DH5a, a

mutant that does not contain plasmids and Mycobacterium
paratuberculosis were selected to demonstrate the
isolation of genomic nucleic acids.

Nucleic acids
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were found within the H20 extracts in both M.
paratuberculosis and

coli.

Methanol extracts

contained a small amount of nucleic acid, as would be
expected, since GC/MS results have also indicated the
presence of purines and pyrimidines in this extract.
This may represent the free nucleotide pool of the
cells.

Measurable amounts of nucleic acids were not

found in the remaining solvent extracts.

The OD

260/280 ratio of the H20 extracts was 2.1 (M.
paratuberculosis) and 1.54 (E. coli) with recoveries
from 0.5 gm bacteria (pelleted wet weight) of 4.26 mg
(M. paratuberculosis) and 5.0 mg (E. coli).

Further

studies concerning the isolation of genomic and plasmid
DNA with this technique from bacteria and its
suitability for restriction enzyme digestion are also
complete.

Both genomic and plasmid DNA can be

recovered with minor modifications to the MSPD
technique and digestion of the DNA with various
restriction endonucleases can be accomplished (25).
Since JSj. coli has large quantities of
lipopolysaccharide (LPS), we examined the

coli HX,

DCM, ACN, MeOH and H 20 extracts for the presence and
quantity of LPS using an assay system that quantitates
2-keto-3-deoxyoctonic acid (KDO), a component of the
LPS of Gram (-) bacteria (24).

The data indicated that
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LPS was detectable only in the H20 extract and recovery
from 0.5 gm L. coli (pelleted wet weight) was 325.4 ng.

Advantages and Applications

Based on the data presented, it is proposed that
the MSPD technique is a novel method for the lysis and
subsequent fractionation of bacteria, in a single step,
that is chemically and physically mild and could
greatly reduce the time and eliminate many of the
problems associated with classical methods of cell
lysis and subsequent fractionation of components.

In

essence, MSPD is a combination of the classical
techniques of grinding with abrasives and detergent
solubilization of cell membranes for cell disruption
and step gradient reverse-phase chromatography for
fractionation.

However, in MSPD the detergent is bound

to a solid support thereby eliminating many of the
problems arising from the use of soluble detergents.
While distinct classes of compounds are found in
different fractions from the MSPD columns, the degree
of purification obtained may not be adequate for all
applications.

Virtually no fractionation of the most

polar, water soluble compounds is achieved, other than
their removal from the less polar compounds of the cell
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matrix.

Thus, further fractionation may be required.

As applied here, MSPD does provide a partial
fractionation of classes of materials.

Greater

fractionation may be obtained by deviating from the
elution profile utilized here and will be a function of
the needs of the analyst.

Nevertheless, we are unaware

of another technique that is currently available that
can accomplish a similar degree of lysis and
fractionation in a single, simple, inexpensive step.
This report demonstrates that this technique is
capable of fractionation of classes of compounds (i.e.
lipid, carbohydrate, protein and nucleic acids) from
two distinctly different bacterial genera.

It is also

demonstrated that phospholipids can be separated from
neutral lipids and the data suggests that membrane
associated proteins (hydrophobic) may be separated from
cytosolic and possibly other proteins.

The variables

involved in MSPD may provide sufficient flexibility to
make this approach generally applicable as a one-step
lysis and

partial fractionation technique for various

types of cells.

Although C18 polymer was examined

here, it may also be possible to obtain similar results
using other lipophilic polymers or amphiphiles
covalently bound to solid supports.

Such materials

could also be used to provide unique characteristics
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for different applications of disruption and
fractionation.

A further factor may also be the ratio

of polymer bound solid support material to the amount
of pelleted cells or tissue to be blended.

An

increased ratio of free polymer to cell matrix may
provide a higher degree of fractionation.

The elution

profile that can be chosen

is also highly flexible.

is feasible that through a

combination of these

variables, one could blend

the sample and begin the

It

elution sequence with a polar solvent (depending on the
compound of interest), rather than the non-polar
sequence examined in this report.

In this manner, one

could perform rapid lysis and preliminary isolation/
fractionation of proteins, nucleic acids, etc. or
remove these species as to isolate more non-polar
species such as phospholipids or sterols.

It is

proposed that the MSPD lysis and fractionation
technique may have broad applicability to other
bacteria, other classes of microorganisms (fungi,
protozoa and metazoan parasites) as well as mammalian
cells or tissue.

Figure 1A.

SEM photomicrograph of the

material with no bacteria.

C18 packing

Figure IB.

SEM photomicrograph of the silica packing

material (no C18) with iL. paratuberculosis.
clumps of intact bacteria (arrows).

Note the
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Figure 1C.

SEM photomicrograph of the C18 packing

material with

paratuberculosis.
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Figure ID.

SEM photomicrograph of the C18 packing

material with Ejl. coli.

Note the "kiss mark",

demonstrating the uniform distribution of the cell
constituents on the surface of the particle (arrow).
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Figure 2A.

Silver stained SDS-PAGE gel of M.

paratuberculosis HSPD extracts. (Lane 1)
extract; (Lane 2)

Methylene chloride extract? (Lane 3)

Acetonitrile extract; (Lane 4)
5)

Hexane

Methanol extract; (Lane

H20 extract? Molecular weight standards (Low

molecular weight calibration kit, Pharmacia-LKB).
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Figure 2B.

Silver stained SDS-PAGE gel of

extracts. (Lane 1)

Hexane extract; (Lane 2)

chloride extract; (Lane 3)
4)

coli MSPD
Methylene

Acetonitrile extract; (Lane

Methanol extract; (Lane 5)

H20 extract; Molecular

weight standards (Low molecular weight calibration kit,
Pharmacia-LKB).
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Table 1.

Mass balance recoveries for Mycobacterium

paratuberculosis.
triplicate.

Determinations were performed in

Averages +/- standard deviations of

percent recoveries for each source are presented.

Source

Percent Recovery

Hexane

14.70% (+/" 4.73%)

Methylene chloride

40.60% (+/- 3.30%)

Acetonitrile

16.60% (+/- 6.10%)

Methanol

17.20% (+/~ 2.80%)

H 20

11.20% (+/“ 0.40%)

Remaining on column
Total Accounted for

6.80% (+/- 0.50%)
99.97% (+/- 4.73%)
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Table 2.

Distribution of proteins in M.

paratuberculosis and

coli extracts by Markwell

protein determination.

Determinations were done in

triplicate.

Averages +/- standard deviations are

presented.

ML. paratuberculosis £L_ g-Qli
extracts (mg/ml)

extracts (mg/ml)

Hexane

o.oo +/-0.000

0.00 +/“0*000

Methylene chloride

0.94 +/-0.396

0.00 + / - 0.000

Acetonitrile

0.08 +/-0.023

0.16 +/“0.130

Methanol

0.44 +/-0.040

0.51 +/-0.067

h 2o

0.99 +/—0.260

8.06 +/—0 .116
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Table 3. Sumary of coapounds identified fron L paratuberculosis (HP) and L. sali (EC)
MSPD extracts derivatized as fatty acid aethylesters or as triaetbylsilyl derivatives.
(FAH)= Fatty acid aethyl esters; (AA)=Aaino acids; (MOHO)=Honosaccharides; (DI)= Disaccbarides; (IHD)=Indoles; (QUIN)=Quinolines; (IHOS)-Inositols; (SFA)-Short chain fatty
acids; (PYR)=Pyrinidine; (BENZ)=Benzene acids; (CIT)=Citric acid.

Bexane

HP

Hethylene chloride

EC

HP

EC

Acetonitrile

Methanol

HP

EC

HP

EC

C-14 FAR C-12 FAH

C-14 FAH C-12 FAH

SFA

PYR

C-14 FAH C-14 FAH

C-15 FAH C-16 FAH

C-15 FAH C-14 FAH

Sterols IND

C-15 FAH C-15 FAH

C-16 FAH

C-16 FAH C-18 FAH

BENZ

C-16 FAH C-16 FAH

C-17 FAH

C-17 FAH C-19 FAH

Sterols

C-17 FAH C-17 FAH

C-18 FAH

C-18 FAH SFA

C-14 FAH

C-18 FAH C-18 FAH

C-19 FAH

C-19 FAH IND

C-19 FAH C-19 FAH

C-20 FAH

C-20 FAH QUIN

C-20 FAH AA

C-22 FAH

C-24 FAH

C-24 FAH IND

C-24 FAH

AA

Purines

INOS

PYR

HONO

ODIN

DI

HONO

CIT

DI
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ABSTRACT
A novel method for the lysis and subsequent
isolation of nucleic acids from Mycobacterium
par atubercu 1os is strain 18 and an EL*.

strain

containing the plasmid pUC19 is described utilizing the
technique of matrix solid-phase dispersion (MSPD).
Bacteria were blended with octadecylsilyl (C18)
derivatized silica to obtain complete cellular lysis.
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The blended material was used to prepare a column which
was eluted with Tris-EDTA buffer (TE buffer).

After

subsequent purification by standard methods, isolation
of cellular nucleic acids were confirmed by
spectrophotometric analysis and ethidium-bromide
agarose gel electrophoresis.

Restriction endonuclease

digestion of the purified DNA was performed to
demonstrate the possible applicability of the MSPD
technique as a general method for the lysis and
subsequent isolation of nucleic acids from bacteria.

INTRODUCTION

Mycobacteria, such as Mycobacterium
paratuberculosis (MPARA) or Mycobacterium aviumintracellulare (MAI), require extremely severe
procedures for disruption, such as treatment with
antibiotics (ampicillin and D-cycloserine) and high
concentrations of SDS or extended sonication (20
minutes at maximum capacity) (2,3).

In contrast, the

bacterium Ej_ coli. can be readily disrupted by
treatment with lysozyme and low concentrations of
sodium dodecyl-sulfate (SDS) (1) or short bursts of
sonication.

Indeed, mycobacteria are some of the most

difficult bacteria to disrupt due to the thickness of
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their cell walls.

Often these techniques do not result

in complete lysis and added detergents, etc. must be
removed.

Sonication often fragments nucleic acids and

greatly increases the chance of aerosolization of
infectious organisms.

Because many mycobacteria are

difficult to culture and the recent interest in AIDSrelated mycobacterial infections, a more efficient
technique for the lysis and subsequent isolation of
nucleic acids is needed.
Presented here is a new approach called matrix
solid phase dispersion (MSPD), for the complete lysis
and subsequent isolation of nucleic acids from
mycobacteria.

The use of MSPD eliminates many

difficulties associated with the current methods of
disruption

of mycobacteria and can be accomplished in

minutes without SDS or enzymatic treatment.

This one-

step approach is chemically and physically mild,
employing the use of a lipophilic polymer (C18) bound
to a solid support (silica) to lyse and disperse
cellular components.

The product is a semi-dry, easy

to handle column packing material from which various
cellular constituents can be sequentially eluted from a
single sample using small volumes of solvents (4,5,6).
In this report, we present the first application of
this methodology for the isolation of genomic DNA from
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MPARA and plasmid DNA from an SL*. coli strain DH5a
containing the plasmid pUC19 (EpUC19).

MATERIALS AND METHODS
Bulk C18 (22 gm, 40 tm, 18% load, end-capped,
octadecylsilyl derivatized silica, Analytichem Int.,
Harbor City, CA) was placed in a column (50 ml syringe
barrel) and sequentially washed with two column volumes
each of hexane (HX), methylene chloride (DCM), and
methanol (MeOH) by vacuum aspiration (vacuum box) until
dry to remove contaminants inherent in manufacture.
Elution columns (6.0 ml) (Analytichem Int., Harbor
City, CA) containing polypropylene frits as porous
bottom retainers were thoroughly washed and dried prior
to use.

A 100 jiil disposable pipette tip trimmed to

fit the syringe tip was used to slow the column flow
rate.

Triplicate bacterial samples of 0.5 gm were

uniformly blended with C18 (MPARA - 3.0 gm, EpUC19 3.0 gm) in a mortar and pestle (total blending time
approximately 30 seconds).

A portion of the blended

material (1.75 gm) was transferred to columns as
prepared above.

The material was packed into the

column using a syringe plunger and a 1.5 cm Whatman No.
1 filter was placed on top as a retainer.
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Bacterial cultures were obtained commercially
(MPARA from ATCC, Rockville, MD and EpUC19 from BRL,
Gathersburg, MD).

MPARA was grown in Middlebrooks 7H9

Broth (Difco Labs, Detroit, MI) supplemented with 100
ml/L Middlebrooks OADC Supplement (Difco Labs, Detroit,
MI) and 2.0 mg Mycobactin J (Allied Labs, Glenwood
Springs, CO) at 37° C for 21 days prior to harvest.
EpUC19 was grown in Luria-Bertani media (10 gm
Bactotryptone (Diffco), 5.0 gm yeast extract (Difco),
10 gm NaCl, pH 7.4) at 37° C for 24 hours prior to
harvest.

Bacterial cells were harvested by

centrifugation (1,000 x g for 10 minutes) and washed
twice with Standard Buffer (20 mM Tris-HCl, 2.0 mM
MgCl2 [pH = 7.5]).
All standard compounds, ribonuclease and solvents
were obtained from commercial sources (Sigma Chemical
and Fisher Chemical) and were of the highest purity
available.

Restriction endonucleases were obtained

from BRL Laboratories (Gathersburg, MD).

Water for

buffers was triple-distilled water polished by a
Modulab Polisher I (Continental Water Systems Corp.,
San Antonio, TX) water purification system.
Spectrophotometric determinations were performed on a
Lambda 3A spectrophotometer (Perkin Elmer Corp.,
Norwalk, CT).

Agarose gel-electrophoresis was
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performed using 7.0 x 10.0 cm 1.0% agarose gels in a
horizontal mini-gel apparatus with a EC-103 power
source (E-C Apparatus Corp., St. Petersburg, FL) at 50
mV for approximately 2.0 hours in tris-acetate buffer.
Weights were obtained using a Mettler H31AR balance.
Triplicate samples of 2L. mratuberculosis and
EpUC19 (0.5 gm each) were prepared as described
previously using the MSPD technique.

The following

solvent elution sequences were performed and evaluated:
(A) Hexane (HX), Dichloromethane (DCM), Acetonitrile
(ACN), Methanol (MeOH) and TE buffer (10 mM Tris, 5 mM
EDTA); (B) Methanol and TE buffer; and (C) TE buffer
alone.

Appropriate volumes (7.0 ml) of solvent were

poured into the packed column and allowed to filter
through by gravity flow.

Retained solvent was removed

from the column using air pressure generated by a
pipette bulb.

Solvent fractions were collected in

either 15 ml or 50 ml polypropylene cone-bottomed tubes
with screw caps.

The HX, DCM, ACN and MeOH fractions

were evaporated to dryness under dry nitrogen and
stored at -20°C.

The TE buffer extracts of EpUC19 were

adjusted to pH 12.5 (5 Ml 10N NaOH per 1.0 ml eluate)
mixed well, placed on ice for 10 minutes, neutralized
with one-half volume of Solution III (3 M potassium
acetate buffer (3 M K+ , 5 M acetate)) (1), placed on
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ice for another 10 minutes and centrifuged at 4°C in
Sorvall SS-34 rotor at 10,000 x g for 30 minutes.
The proteins of MPARA and EpUC19 were removed by
extraction with equal volumes of TE saturated phenol,
equal volumes of TE saturated phenol-chloroform (1:1)
and equal volumes of TE saturated chloroform and the
nucleic acids were precipitated with equal volumes of
isopropanol and centrifugation at 4°C in SS-34 rotor at
10,000 x g.

The nucleic acid pellet was washed once

with ice-cold 70% ethanol, dried under vacuum and
resuspended in 0.5 ml TE buffer.
Genomic DNA from MPARA was purified by digestion
with ribonuclease (final concentration 20 /jg/ml) at
room temperature (RT) for 45 minutes), precipitation
with 0.1 volumes of 3 M sodium acetate and two volumes
of ethanol, incubated at -20 °C for 60 minutes,
centrifuged at 12,000 X g at 4°C for 10 minutes in a
microcentrifuge, dried under vacuum and
0.5 ml TE buffer.

resuspended in

Plasmid DNA from EpUC19 was purified

by precipitation with polyethylene glycol 8000 (PEG
8000) (1).
The presence of nucleic acids was determined
spectrophotometrically by absorbance at 260 nm and by
the presence of fluorescent bands on a 1.0% agarose
mini-gel after staining with ethidium bromide (EtBr).
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The quality of the nucleic acid preparation was
determined using the OD 260/280 ratio and the quantity
was determined using the OD 260 (7).
Restriction endonuclease digestion using the
restriction enzymes BamHI, EcoRI, HindIII/ Pvul, and
PvuII on MPARA genomic DNA (10.0 fig) and EpUC19 plasmid
DNA (3.0 fig) was performed utilizing the reaction
conditions described in the product insert (BRL,
Gathersburg, MD), with minor modifications.
Approximately 20 U of each enzyme was used when MPARA
genomic DNA was used (10 U for Pvul) and 6 U of each
enzyme was used when EpUC19 plasmid DNA was used (3 U
for Pvul).

The reaction volume was 50 fil and

incubation was at 37°C for 60 minutes then 4°C
overnight.

RESULTS

Nucleic acids were found within the TE buffer
extracts of both MPARA and EpUC19.

Methanol extracts

contained a small amount of nucleic acid.

Measurable

amounts of nucleic acids were not found in the
remaining solvent extracts (HX, DCM, ACN).

Nucleic

acid pellet weights of each treatment after protein
extraction are presented in Table 1.

The relative
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recovery of plasmid DNA from EpUC19 after removal of
contaminants and purification by PEG 8000 is presented
in Table 2.

The differences in plasmid DNA yield

(EpUC19) of the various solvent sequences is
demonstrated visually in Figure 1.

The highest yield

of genomic and plasmid DNA is obtained when the MSPD
column is eluted with TE buffer alone (Tables 1, Table
2 and Figure 1).

Using the MSPD technique with TE

buffer alone, approximately 425 fig of purified pUC19
DNA can be obtained from 0.5 gm EpUC19 (wet weight).
Digestion of both plasmid DNA (Figure 2) and
genomic DNA (Figure 3) was accomplished using the
following restriction endonucleases:
Hindlll, Pvul and PvulI.

BamHI, EcoRI,

Figure 2 clearly demonstrates

complete digestion of the pUC19 DNA, since pUC19 has
only one restriction site for BamHI, Hindlll and EcoRI
and has two restriction sites for Pvul and PvuII (1).
Although not as obvious as the pUC19 digests, the fine
striations observed in the lanes of Figure 3
demonstrate that MPARA genomic DNA obtained by MSPD is
also cleaved by the various restriction enzymes.

DISCUSSION

Matrix Solid Phase Dispersion columns were eluted
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with three different solvent sequences.

Samples of

EpUC19 were treated similarly for purposes of
comparison.

Nucleic acids were found within the TE

buffer extracts in both MPARA and EpUC19.

Methanol

extracts contained a small amount of nucleic acid, as
would be expected, since previous GC/MS analysis

have

also indicated the presence of purines and pyrimidines
in the extracts from MPARA and

coli strain DH5a (6).

This may represent short oligonucleotides or the free
nucleotide pool of the cells.

Methanol may precipitate

the nucleic acids within the column assemblage, thereby
decreasing the solubility of the nucleic acids in TE
buffer and decreasing yield.

The highest yield of

genomic and plasmid DNA is obtained when the MSPD
column is eluted with TE buffer alone.

In comparison

to the alkaline-lysis technique for EpUC19, (1,8) the
yields obtained from EpUC19 by the MSPD technique are
quite comparable.

An overnight culture of EpUC19 in LB

media (1 liter) usually provides 1.5 to 2.0 gm of
bacteria (wet weight) and yields of purified pUC19 DNA
range from 1.0 to 2.0 mg DNA (unpublished
observations).

Approximately 1.28 to 1.70 mg of pUC19

DNA could theoretically be obtained from an overnight
culture of EpUC19.
Restriction endonuclease digestion with a variety
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of enzymes demonstrate that the DNA obtained using the
MSPD technique from MPARA and EpUC19 was of sufficient
quality and quantity to be used for various recombinant
DNA methodologies.
The mechanisms for the process of cell lysis and
dispersion of the cellular components by MSPD, occur by
both mechanical and hydrophobic forces.

Grinding of

cells with abrasives (silica or alumina particles) has
been used to lyse bacteria but does not always result
in complete disruption.

The MSPD technique adds a

lipophilic polymer (C18) covalently bound to a similar
irregularly shaped abrasive material (silica).

The

material is also end-capped, with silicate functional
groups not initially derivatized by Clg in the
manufacturing process being sequentially converted to
silicate ethers, producing a highly lipophilic surface.
The material is identical to that used for the
manufacture of reversed-phase solid-phase extraction
columns (HPLC).

As utilized here, it is thought that

the polymer assists in the disruption process by
solubilizing membrane lipids.

This solubilization of

the cell membranes result in a uniform dispersion of
bacterial constituents over the surface of the Clg
derivatized particles (4, 5, 6).
This dispersion of materials also forms a
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polymer/tissue matrix assemblage on a solid support
that can be packed into a column.

At the ratios of Clg

to pelleted bacteria examined here,

the material

obtained after blending is semi-dry and easily
transferred to a column housing for subsequent elution.
Due to the nature of this dispersion, sequential
elution of columns prepared from these materials with
solvents of increasing polarity would be expected to
result in the sequential solubilization and elution of
compounds of like polarity (4, 5, 6).
The MSPD technique is a novel method for the lysis
and subsequent isolation of DNA from bacteria that is
chemically and physically mild and greatly reduces the
time and eliminates many of the problems associated
with classical methods of mycobacterial cell lysis.
Although the technique works equally well with £L±. coli
and other bacteria (unpublished data), it probably does
not offer significant advantage over the alkaline-lysis
procedure of Birnboim and Doly (8) in bacteria that are
relatively easy to disrupt.

It is suggested that the

MSPD lysis and fractionation technique may offer great
advantage to those working with mycobacteria or other
organisms that are difficult to disrupt with classical
techniques.
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Table 1.

Mean nucleic acid recovery from different

MSPD solvent sequences following partial purification.

SOLVENTS

MPARA

EpUC19

HX, DCM, ACN, MeOH, TE buffer

.00470 gm

.00875 gm

MeOH, TE buffer

.01280 gm

.01845 gm

TE buffer

.02310 gm

.02430 gm

MPARA = Mycobacterium paratuberculosis (0.5 gm); EpUC19
= EL*. coli strain containing pUC19 plasmid (0.5 gm).
(n=2).
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Table 2.

Mean relative plasmid DNA recovered from 0.5

gm EpUC19 utilizing three different MSPD solvent
sequences.

SOLVENTS

OD 260/280

TOTAL DNA

HX, DCM, ACN, MeOH, TE buffer

1.91

95

MeOH, TE buffer

1.73

300

TE buffer

1.66

425

*

n=2

m
Mg
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C

Figure 1.

B

A

Relative yield of PEG-8000 purified pUC19

DNA from various MSPD solvent sequences demonstrated by
ethidium bromide stained 1.0% Agarose gel
electrophoresis.

Lane (A) - HX, DCM, ACN, MeOH, TE

buffer sequence; Lane (B) - MeOH, TE buffer sequence;
Lane (C) - TE buffer alone.
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Figure 2.

Restriction endonuclease digestion PEG-8000

purified pUC19 plasmid DNA as demonstrated by ethidium
bromide stained 1.0% agarose gel electrophoresis.

Lane

(A) - uncut pUC19 DNA; Lane (B) - BamHI digest; Lane
(C) - EcoRI digest; Lane (D) - HindiII digest; Lane (E)
- Pvul digest; Lane (F) - PvuII digest.

Figure 3.

Restriction endonuclease digestion of MPARA

genomic DNA as demonstrated by ethidium bromide stained
1.0% agarose gel electrophoresis.

Lane (A) - uncut

MPARA genomic DNA; Lane (B) - BamHI digest; Lane (C) EcoRI digest; Lane (D) - HindiII digest; Lane (E) Pvul digest; Lane (F) - PvuII digest.
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ABSTRACT
Fractions exhibiting activity detrimental to the
killing of gamfljlfla albicans (CA) by activated bovine
monocyte/ macrophages (M<p)

were obtained from

ttePJaagterlhro paratuberculosis (MPARA) strain 18.
Active fractions were derived utilizing the Matrix
Solid Phase Dispersion (MSPD) technique, which is a
novel method of lysis and partial fractionation of
components of bacterial cells.

Further fractionation

of active fractions was achieved using Concanavalin A
affinity chromatography and centrifugal filtration.

As

many as three different fractions derived from two
MPARA extracts that exhibited marked inhibition of M<p
killing ability were isolated and partially
characterized using SDS-PAGE, thin layer chromatography
(TLC), enzymatic, and chemical treatments.

Two active

fractions demonstrated characteristics of glycolipids
and a third active fraction had characteristics
compatible with a peptidoglycolipid.
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INTRODUCTION

Bovine paratuberculosis (Johne's Disease) is a
chronic, debilitating, granulomatous, enteric disease
caused by infection with the acid-fast bacillus
Mycobacterium paratuberculosis (8).

Paratuberculosis

is primarily a disease of domestic ruminants occurring
throughout the world; however, numerous species of
wildlife (7, 28, 47, 63) and monogastric domestic
animals (34, 35, 47) have been naturally or
experimentally infected.
Mycobacterium paratuberculosis also has been
implicated as a human pathogen, since a mycobacterial
species with the morphological features and growth
characteristics identical to MPARA, which by DNA probe
analysis is identical to MPARA strain 19698, has been
isolated from three non-AIDS infected human patients
with Crohn's Disease (9, 10, 11, 39, 40).

Similarities

in morphology and a close antigenic relationship
between MPARA and |L_ avium surface glycopeptidolipids
has been noted (4).

Comparisons of various

mycobacterial species by DNA probe analysis also has
demonstrated that MPARA strain 18 is identical to M.
avium serovar 2^ (41).
In the United States, it has been estimated that
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the prevalence of herd infection by MPARA is between 5%
and 20% and that the losses to the dairy industry alone
exceed $1.5 billion per year (8).

In Louisiana, a

recent survey in beef cattle herds revealed that 4.4%
of the animals tested and 30% of the herds tested were
seropositive on the ELIZA test with an estimated annual
loss to the Louisiana beef industry of $ 2,003,710.00
(59).
As with other mycobacterial diseases, MPARA is
phagocytized by macrophages and the organism somehow is
protected intracellularly within the resident
macrophages against humoral and cellular defense
mechanisms (44).

The prominent glycolipid containing

capsule of the mycobacteria is thought by some
researchers to form an indigestible, hydrophobic
interface between the bacterium and the host cell, thus
preventing intracellular digestion (2).

Currently,

little or no research has addressed the possibility of
the production of a factor/s by MPARA that inhibits the
killing function of bovine Mip.

This is an active area

of research currently being investigated with M.
tuberculosis (60, 61) and £L. lepxaa (48, 49, 50, 31).
A number of compounds have been isolated from
various species of mycobacteria that exhibit biological
activity.

Phenolic glycolipids from several strains of
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mycobacteria are potent inhibitors of lymphocyte
proliferation in a concentration dependent manner and
the inhibition is independent of the stimulus used.
The mechanism appears due to a nontoxic functional
effect on proliferating CD4+ lymphocytes that is
nonspecific and the inhibition may be a general
property of the glycolipid (20).

Phenolic glycolipids

isolated from !L_ leprae. M. tuberculosis and H*. bovis
(i.e.PGL-I) have been shown to be highly immunogenic,
useful for serological diagnosis and to have
significant deleterious effects on phagocytes (2, 5, 6,
23, 21).
Mycobacterial lipoarabinomannan (LAM) is also a
potent inhibitor of in vitro proliferation of human
peripheral blood mononuclear cells (18) and of gamma
interferon mediated activation of mouse macrophages in
vitro (50).

The mycobacterial LPS#s , 1ipoarabinomannan

(LAM) and mycolylarabinogalactan, are inherently part
of the mycobacterial cell wall, highly immunogenic and
known to inhibit phagocyte function (2, 21, 29).
Lipoarabinomannans are widely distributed among
mycobacteria where they are covalently linked to
phosphoinositol in the cell membrane and are the major
immunogens recognized by sera of infected patients (25,
43).

Gamma interferon, but not Interleukin-4 or Tumor
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Necrosis Factor have been shown to activate
tuberculostatic functions in murine macrophages against
M. bovis (19).

Similar immunosuppressive results have

been demonstrated with the glycopeptidolipids of
Mycobacterium aviurn-intrace11ulare complex, which also
interfere with subsequent proliferation of murine
lymphocytes (20, 3, 56).

However, treatment of human

monocytes with gamma interferon decreased phagocytosis
and had no effect on the intracellular replication of
M. avium, suggesting that gamma interferon does not
have macrophage-activating activity for &*_ avium
infected human monocytes (58).

A group of

glycopeptidolipid surface antigens related to "mycoside
C" of the JL avium group have also been shown to be
inhibitory to phagocytes (2).

A glycolipid (polar GPL-

I) isolated from JL paratuberculosis by thin layer
chromatography (TLC) has been found to be antigenic and
specific to the organism (4).
A 25 Kilodalton (Kd) glycolipoprotein from
Mycobacterium tuberculosis has been demonstrated to
inhibit the intracellular killing of Candida albicans
by macrophages and Staphylococcus aureus by neutrophils
(60).

This inhibitory effect was reversed by the

addition of gamma interferon (60).

This 25 Kd

glycolipoprotein has also been shown to inhibit hexose
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monophosphate shunt activity, lysozyme release, and
H202 production again reversed by the addition of gamma
interferon (61).
Sulfolipid I isolated from 2L. tuberculosis has
been shown to be taken up in significant amounts by
human neutrophils and in lesser amounts by monocytes
and lymphocytes (42).

Superoxide production by these

neutrophils was increased at low to moderate
concentrations of sulfolipid I (<27 ng/ml), while
higher concentrations of the compound resulted in
significant depression of 02“ production.

This effect

was prevented if the monocytes were pretreated with
gamma interferon (53).

A sulfatide present on the

outer surface of SL_ tuberculosis was shown to inhibit
macrophage priming (45).

Sulfolipids may also promote

bacterial virulence by enhancing the toxicity of "cord
factor" (trehalose 6,6#-dimycolate) (22).
Cord factor has both immunostimulant and toxic
properties (22).

Cord factor is found in a variety of

bacteria including the mycobacteria, corynebacteria and
nocardia with virulent strains typically possessing
larger amounts (45, 51).

Cord factor induces the

production of tumor necrosis factor in mice resulting
in cachexia and eventually death (51).
Four mycobacterial cell wall lipids have been
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tested for their effects on phospholipidic liposome
organization, passive permeability and oxidative
phosphorylation of isolated mitochondria (53).

It was

concluded that the trehalose-containing lipids
(dimycoloyltrehalose and polyphthienoyl-trehalose)
rigidified the fluid state of liposomes; whereas,
triglycosyl phenolphthiocerol slightly fluidized the
gel state and peptidoglycolipid (apolar mycoside C)
shifted the phase transition temperature upward.
Dimycoloyltrehalose did not affect liposome passive
permeability; whereas, triglycosyl pheno1phthiocerol
slightly decreased leaks and mycoside C greatly
increased leaks.

Both trehalose-containing lipids

demonstrated inhibitory activity on oxidateive
phosphorylation of mitochondria, while triglucosyl
phenolphthiocerol was inactive and mycoside C was very
active (53).
As described above, there are many compounds
produced by mycobacteria that have been shown to
inhibit lymphocyte proliferation or to inhibit
phagocyte function thereby enabling the organism to
survive and multiply within the macrophage.

Many of

these compounds are structural components of the
mycobacterial cell wall (2).

The mechanisms by which

these compounds act are currently unknown.

To this
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end, future research roust be aimed at isolating,
characterizing and then modulating the effects of these
compounds.

Clarification of the intracellular survival

mechanisms of MPARA may provide information that would
contribute to the understanding, prevention and
treatment of related human mycobacterial diseases such
as leprosy, tuberculosis, non-tuberculous AIDS related
mycobacterial infections and possibly Crohn's Disease
(Regional Ileitis).

The clarification of MPARA's

interaction with host cells as mediated by pathogenproduced inhibitory factors is expected to have broad
application to human and veterinary mycobacterial
diseases.

MATERIALS AND METHODS

General
Bacterial cultures of IL_ paratuberculosis strain
18 (ATCC, Rockville, MD) and a non-pathogenic strain of
E. coli (DH5a; BRL, Gathersburg, MD) were obtained from
commercial sources.

E±. paratuberculosis

was grown in

Middlebrooks 7H9 Broth (Difco Labs, Detroit, MI)
supplemented with 100 ml/L Middlebrooks OADC Supplement
(Difco Labs, Detroit, MI) and 2.0 mg Mycobactin J
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(Allied Labs, Glenwood Springs, CO) at 37° C for 21
days prior to harvest.

coli was grown on Luria-

Bertani media (10 gm Bactotryptone (Difco), 5.0 gm
yeast extract (Difco), 10 gm NaCl, pH 7.4) at 37° C for
24 hours prior to harvest.

Bacterial cells were

harvested by centrifugation (5,000 x g for 10 minutes)
and washed twice with Standard Buffer (20 mM Tris-HCl,
1.0 mM MgCl2 [pH = 7.5]).
All standard compounds and solvents were obtained
from commercial sources (Sigma Chemical and Fisher
Chemical) and were of the highest purity available.
Water for dialysis, SDS-PAGE buffers and solutions was
triple distilled water polished by a Modulab Polisher I
(Continental Water Systems Corp., San Antonio, TX)
water purification system.

Spectrophotometric

determinations were performed on a Lambda 3A
spectrophotometer (Perkin Elmer Corp., Norwalk, CT).

Sample Preparation r MSPP

Bulk C1Q (22 gm, 40 fm, 18% load, end-capped,
octadecylsilyl-derivatized silica, Analytichem Int.,
Harbor City, CA) was placed in a column (50 ml syringe
barrel) and sequentially washed with two column volumes
each of hexane (HX), methylene chloride (DCM), and

methanol (MeOH) by vacuum aspiration until dry to
remove contaminants inherent in manufacture. Syringe
barrels (10 ml), which were used to prepare elution
columns for samples, were thoroughly washed and dried
prior to use.

Filter paper discs (1.5 cm, Whatman No.

1) were used as retainers for the c18 material within
elution columns.

A 100 fil disposable pipette tip

trimmed to fit the syringe tip was used to slow the
column flow rate (1, 36, 37).

Samples of MPARA and E.

coli (0.5ctm) were uniformly blended with C18 (3.0 gm)
in a mortar and pestle and transferred to columns as
prepared above (total blending time approximately 30
seconds).

The material was packed into the column

using a syringe plunger and a 1.5 cm Whatman No. 1
filter was placed on top as a retainer.

Appropriate

volumes of HX, DCM, Acetonitrile (ACN), MeOH and H20
(10.0 ml) were poured into the column and allowed to
filter through the column by gravity flow.

Retained

solvent was removed from the column using air pressure
generated by a pipette bulb.

Solvent fractions were

collected in either 10 ml glass cone-bottomed tubes or
15 ml polypropylene cone-bottomed tubes with screw
caps.

The HX, DCM, ACN and MeOH fractions were

evaporated to dryness under dry nitrogen.

Water

extracts were lyophilized to dryness (24).

All

133
fractions were resuspended in 1.0 ml H20 and stored
frozen at ~20°C prior to testing in the M<p-CA killing
assay.

Sample treatments

Protein was destroyed in the ACN and H 20 MPARA
MSPD fractions in the following manner.

Portions of

protease K (20 mg dry weight, 0.5 units activity),
insolubili2ed by covalent binding to 4.0% agarose beads
(Sigma), was washed 5 times using 0.5 ml H20 in a
centrifugal filtration unit (Costar spin X, Cambridge,
MA) containing a 0.45/im cellulose acetate membrane at
5,200 x g for 5 minutes in a microcentrifuge.

The

retentate (protease K - agarose was resuspended within
the upper chamber with 0.5 ml of each sample and
transferred to fresh a tube containing the remainder of
each sample.

Samples were incubated for 24 hours at

37°C with occasional shaking.

After incubation, each

sample was filtered in a microcentrifuge at 12,000 x g
using 0.45/im centrifugal filtration units (Costar,
Cambridge, MA) to remove the protease K - agarose.
Blanks consisted of similarly treated H20.
Lipid was removed from the ACN and H20 MPARA MSPD
fractions in the following manner.

Triple volumes of
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chloroform (3.0) was added to each sample and mixed
thoroughly by vortexing.

After centrifugation at 650 x

g for 4 minutes the supernate was removed by aspiration
and transferred to a clean tube.

This procedure was

repeated three times and then each sample was
lyophilized to remove traces of chloroform.
consisted of similarly treated H20.

Blanks

Samples were

resuspended in 1.0 ml H20 and stored frozen at -20°C
prior to testing.
Sodium metaperiodate treatment of the ACN and H20
MPARA MSPD samples to damage carbohydrate groups was
accomplished by adding 3.0 mis of a 50 mM sodium
metaperiodate solution in a 1 M sodium acetate buffer
(pH 6.0) to 1.0 ml of each sample and incubating at RT
for 80 hours in the dark with occasional shaking.

The

reaction was terminated by extensive dialysis (5
changes of 4 liters each of SB over 72 hours) (60).
Samples were lyophilized, reconstituted in 1.0 ml H20
and stored frozen at -20°C prior to testing.

Blanks

consisted of similarly treated H20.
Samples of the ACN and H2o MPARA MSPD fractions
were reacted with anti-LAM monoclonal antibodies
obtained using the mouse ascites model to LAM purified
form strain H37Ra JL_ tuberculosis.

The monoclonal

antibody was kindly provided by Dr. P. J. Brennan
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(Colorado State University) in lyophilized form with
sodium azide as a preservative.
for blots, etc. was 1:1600.

The recommended titer

To lyophilized samples of

the ACN and H 20 MSPD samples 1.0 ml of a 1:200 dilution
of the anti-LAM antibody was added and vortexed
vigorously.

Samples were incubated at 4°C for 48

hours, then dialyzed in 3500 MW cutoff dialysis tubing
against 4 changes of 4 liters of SB over 48 hours at
4°C to remove traces of sodium azide.

Samples were

lyophilized, resuspended in 1.0 ml H20 and stored
frozen at -20°C prior to testing.

Blanks consisted of

similarly treated anti-LAM antibody at 1:200 dilution.
The ACN MSPD dry extract from 1.5 gm MPARA was
resuspended in 1.0 ml H20 by vortexing vigorously and
subjected to centrifugal filtration utilizing a
Centricon 30 microconcentrator containing a 30 Kd
cutoff semipermeable membrane (Amicon, Danvers, MA).
The unit was centrifuged in a

45° fixed angle bench

top centrifuge (Clay Adams, Parsippany, NJ) at 1,500 x
g at room temperature (RT) for 3 hours.
was resuspended in 1.0 ml H20.

The retentate

Both retentate and

filtrate were stored frozen at -20QC prior to testing.
Blanks consisted of 1.0 ml SB.
The H20 MSPD dry extract from 1.5 gm MPARA was
resuspended in 3.0 ml H20 and subjected to Concanavalin
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A (ConA) affinity chromatography.

Concanavalin A

covalently bound to 4.0% agarose beads type V-A (ConAAgarose) (Sigma Chemical) in 50% aqueous suspension
(10.0ml) was poured into a plastic disposable 15 ml
econocolumn chromatography column (Biorad, Rockville
Center, NY) and allowed to settle (column bed 5.0 ml).
The column was washed with 10 column volumes (50 ml) of
phosphate buffered saline pH 7.5 (PBS).

The H20

extract (3.0 ml) was allowed to flow through the column
by gravity flow.

The column was then washed with 2

column volumes (10 ml) of PBS.

The column was eluted

in step fashion with 2 column volumes (10 ml) of 1% Dglucose in PBS followed by 2 column volumes (10 ml) of
10% D-glucose in PBS.

The

1% D-glucose, 10% D-glucose

and column flow-through fractions were dialyzed in 3500
molecular weight (MW) cutoff cellulose membrane against
4 changes of 4 liters of HPLC grade H20.

The blanks

consisted of the column flow-through fraction and SB.
The dialyzed samples were then lyophilized to dryness,
resuspended in 1.0 ml H20 and stored frozen at -20°C
prior to testing (modified from Daniels) (13, 14, 15,
16).
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ECQtfiin Quantitation

The presence and quantity of protein was
determined using the Markwell modification of the Lowry
technique that allows for the rapid assay of membrane
and lipoprotein preparations or samples containing
sucrose or EDTA (38).

This modification by the

addition of 1.0% SDS to the alkali reagent, allows the
rapid solubilization

of lipoproteins instead of the

usual time-consuming process of delipidation.

A 4.0%

solution of copper sulfate was added to the SDS
containing alkali reagent to form an alkaline copper
reagent, which was then added to the sample.

After

incubation at room temperature for 10 to 60 minutes,
diluted Folin-Ciocalteu reagent was added, mixed
vigorously and incubated for 45 minutes at room
temperature.

Macrophage r.

Absorbance was recorded at 660 nm (38).

albicans Killing Assay

Bovine peripheral blood mononuclear cells (PBMC)
were obtained from peripheral blood by Ficoll-Hypaque
density gradient centrifugation using Histopaque 1083
(Sigma).

Whole blood (20 mis) was layered gently on 20

mis of Histopaque 1083 in 50ml clear polycarbonate
centrifuge tubes.

Samples are centrifuged at 450 x g
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for 45 minutes at 4°C.

The resultant band containing

PBMC's was removed by aspiration with a long sterile
Pasteur pipette and transferred to a fresh centrifuge
tube containing approximately 30mls phosphate buffered
saline pH 7.5 (PBS).

Cells were washed three times

with PBS (10 ml) then resuspended in RPMI 1640 buffered
with sodium bicarbonate containing lOOng/ml

coli

lipopolysaccharide (LPS), lOOng/ml phorbol myristate
acetate (PMA) per ml, 100/jg ampicillin and 100/ig/ml
streptomycin (Sigma) to a final concentration of
approximately 50,000 M<p per 300/il.

The percentage of

M(p was determined by white blood cell differential
count with confirmation by non-specific esterase
staining (32). The PBMC solution (300/il) was added to
the wells of a 96 well plastic tissue culture plate and
allowed to incubate for 16 hours at 37°C with 5% C02 .
Wells were then washed three times with 300/il of fresh
media to remove the lymphocytes and allowed to incubate
at similar parameters for 8 hours.
Aliquots (25/il) of each fraction collected and
approximately 10,000 Candida albicans cultured
overnight (24 hours) in modified Winge media (.2%
glucose and .3% yeast extract) containing lOOug
Ampicillin and lOOug Streptomycin per ml diluted in
200ul of RPMI 1640 buffered with sodium bicarbonate
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containing lOOug Ampicillin and lOOug Streptomycin were
simultaneously added to each well and allowed to
incubate for 16 hours at 37°C with 5% C02.

A 5.0 ml 24

hour culture of CA yields approximately 2.0 x 10® CFU
CA.

All samples were tested in triplicate.

Viability

of M(p was assessed by exclusion of trypan blue and
viability was consistently greater than 90%.

Plates

were centrifuged at 450 x g for 10 minutes at 4°C and
the supernate discarded.

A 0.02% sodium dodecyl-

sulfate aqueous solution (300/il) was added to each well
to lyse the Mtp and the pellet was resuspended using a
100/xl pipetteman (25 pumps).

Contents of each well was

transferred to a 1.5ml microcentrifuge tube after at
least 1 hour of incubation at 25°C (RT) and vortexed
vigorously.

Dilutions of 102 and 103 were prepared in

1.5ml microcentrifuge tubes using sterile H20 as the
diluent.

Aliquots (50/tl) of each dilution were plated

using a bent Pasteur pipette on 60mm x 15mm culture
plates containing Sabaroud's Dextrose media (Difco).
After 24 hours incubation at 37°C, CFU of CA are
enumerated (modified from Decker et. al) (17).
Statistical analysis (Tukey's Studentized Range Test)
of the obtained CFU was done to analyse the activity of
the suspected active fractions versus control CFU.
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LtoPQ.lysacgharitie quantitation
Quantitation of lipopolysaccharide (LPS) was
performed using standards were prepared from a known
concentration of

coli LPS (Sigma Chemical, St.

Louis, MO) for preparation of the standard curve.
Samples (100/il) from each MPARA extract resuspended in
H20

and standard solutions were tested in the

2-keto-3-deoxyoctonic acid (KDO) assay (29).

The

samples were treated with 0.2 N H2S04 at 100°C for 30
minutes to release the KDO, if present, followed by its
reaction with periodic acid, sodium arsenate and
thiobarbituric acid.
form a red color.

Dimethylsulfoxide was added to

Samples and standards were read at

ABS 548 against the blank (29).

Sample concentrations

were calculated by linear regression analysis.
Lipopolysaccharide was removed from the

coli H20

fraction by affinity chromatography utilizing a
Detoxigel

endotoxin removing affinity gel kit

(Pierce, Rockford, IL) as per kit instructions.

SQS^EASE

Molecular weight standards for SDS-PAGE were
commercially obtained (Low molecular weight
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electrophoresis calibration kit, Pharmacia LKB
Biotechnology, Piscataway, NJ).

Electrophoresis was

performed with a model V16 vertical electrophoresis
system (BRL, Gathersburg, HD) and model EC-103 power
source (E-C Apparatus Corp., St. Petersburg, FL).
Electrophoresis was performed a 4.5% stacking gel and a
12.0% separating gel (pH 6.6 and 8.8, respectively)
(33).

Aliquots of each sample (100 - 200/til were

lyophilized or precipitated in acetone, then
solubilized by heating for 3 minutes at 100°C in 30 /til
sample buffer (10% glycerol, 2% SDS, 5% 2mercaptoethanol, 0.125 Tris-HCl [pH 6.8] and 0.01%
Bromophenol blue).

Gels were run at constant current

of approximately 30 mA in the stack and separating
gels.

Electrophoresis was continued until the tracking

dye was approximately 1.0 cm from the bottom of the gel
(approximately 5.0 hours).
stained primarily

Polyacrylamide gels were

with silver using the technique of

Wray et. al. (64). Apparent molecular weights were
determined by comparison with standards of known
molecular weight:

Phosphorylase B 94 kilodaltons (Kd),

Albumin 67 Kd, Ovalbumin 43 Kd, Carbonic Anhydrase 30
Kd, Trypsin Inhibitor 20.1 Kd and a-Lactalbumin 14.4
Kd.
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Thin Layer Chromatography

Samples of the ACN < 30Kd MSPD fraction (20 /il),
H20 ConA-Agarose 1% D-glucose fraction (40 pi) and the
H 20 ConA-Agarose 10% D-glucose fraction (40/il) were
spotted on a silica gel coated glass TLC plate ( 20cm x
20cm, 19 channel, 250 pm hard surfaced analytical
layer, silica gel with a preabsorbant area, J.T. Baker
Co., Phillipsburg, NJ) and allowed to dry at RT for 30
minutes.

The plate was allowed to develop in a closed

rectangular glass chamber until the mobile phase (50%
chloroform - 40% methanol - 10% H20) was within 2.0 cm
of the top of the plate.

The plate was then removed

and allowed to dry in a chemical fume hood for 20
minutes at RT.

The plate was then sprayed with a

staining solution comprised of 0.01% orcinol and 50%
concentrated sulfuric acid in aqueous solution.

The

plate was then incubated in a convection oven at 120°C
for 15 minutes until distinct bands were visible
(modified from Jarnigan and Colgrove) (27).

RESULTS

Various fractions were obtained from MPARA and a
non-pathogenic strain of E j. coli utilizing the MSPD
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technique.

Marked inhibitory activity was observed in

the ACN and H20 fractions of MPARA and in the H20
fraction of JEu. coli.

Testing of all MPARA and JLa. coli

MSPD fractions utilizing a microassay for KDO,
demonstrated no detectable LPS in all fractions except
the IL*. coli H20 fraction.

After LPS removal from this

fraction by affinity chromatography, the M<p inhibitory
activity was lost (data not shown).
The results of multiple testing of various MPARA
fractions is presented in Figure 1 and demonstrates
marked inhibitory activity in the ACN, DCM and H20 MSPD
fractions.

Comparison of components found in the DCM

and ACN MSPD fractions visualized by SDS-PAGE (Figure
3) and TLC (Figure 6) suggests that some components are
similar between the two fractions.
The quantity of protein present in each MPARA
fraction as determined by the Markwell technique is
presented in Table 1.

Analysis of each MPARA MSPD

fraction by SDS-PAGE gel stained with protein specific
silver staining (64) is presented in Figure 2, while a
similar SDS-PAGE gel stained with a silver stain
designed to stain protein and carbohydrate (57) is
presented in Figure 3.

Note that MPARA MSPD fractions

appear to contain a large number of compounds that are
partly or entirely carbohydrate.

Also note that based
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on Markwell protein determination there is a moderate
quantity of protein in the methanol fraction that is
not visualized in the SDS-PAGE gel (Figure 2).
Results of various enzymatic, chemical and
antibody treatments of the active fractions are
summarized in Figure 4.

A significant reduction in M<p

inhibitory activity resulted from treatment of the ACN
MPARA fraction with protease K, anti-LAM antibody,
sodium metaperiodate and extraction with chloroform;
whereas, similar treatment of the MPARA H20 fraction
demonstrated significant reduction in activity after
sodium metaperiodate treatment and chloroform
extraction.
After separation of the components of the ACN MSPD
extract by centrifugal filtration into > 30 Kd and < 30
Kd fractions, only the less than 30 Kd fraction
demonstrated M<p inhibitory activity (see Figure 4, p
< .0001).

When this fraction was analyzed by SDS-PAGE

with silver staining, no bands were observed (Figure
5).

However, analysis of the fraction by TLC

demonstrated a large band with a very faint smaller
band exhibiting higher relative mobility (Figure 6).
Both the 1% and 10% D-glucose ConA-agarose derived
fractions demonstrated significant inhibitory activity
(p < 0.0001 and p < 0.0001 respectively) while the
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column flow-through fraction had lost essentially all
activity (Figure 4).

The 1% D-glucose fraction

contains three major bands that stain for protein
and/or carbohydrate on SDS-PAGE (67 Kd, 31 Kd, and 5 10 Kd) (Figure 5) and on TLC (Figure 6) the fraction
also contains three bands.

The 10% D-glucose fractions

contains two major bands (65 Kd and 31 Kd) on SDS-PAGE
analysis (Figure 5) and only one band on TLC analysis
(Figure 6).

DISCUSSION

Various fractions were derived from MPARA strain
18 and a non-pathogenic strain of EL*, coli utilizing the
MSPD technique, centrifugal filtration and ConA-Agarose
affinity chromatography.

Marked inhibitory activity

was observed in the ACN and H20 fractions of MPARA and
in the H20 fraction of £±. coli.

After LPS removal

from the £*. coli H20 fraction by affinity
chromatography, the M<p inhibitory activity was lost
(data not shown).

This data suggests that the activity

observed in the MPARA fractions is not due to LPS
contamination and that a nonpathogenic strain of E.
coli does not contain M<p inhibitory compounds similar
to those found in MPARA.

While the DCM MSPD fraction

on some test dates demonstrated significant activity (p
= 0.0122), the activity was not consistent throughout
all test dates.

The ACN and H20 fractions

demonstrated significant activity on all test dates (p
< 0.0002 & p < 0.0001 respectively).

Comparison of

components found in the DCM and ACN MSPD fractions
visualized by SDS-PAGE (Figure 3) and TLC (Figure 6)
suggests that some components are similar between the
two fractions.

This suggests that the cause of the

occasional activity in the DCM MSPD fraction may be
occasional bleed-over of components between the two
fractions.
Based on Markwell protein determination there is a
moderate quantity of protein in the methanol fraction
that is not visualized in the SDS-PAGE gel (Figure 2).
This inconsistency appears due to short peptides and
glycoproteins that remain soluble in 100% methanol that
were suggested by mass spectrometry results (data not
shown) and Figure 3 (bands in lane 4).
The treatment data of the MPARA H20 fraction
suggest that the MPARA H20 fraction is probably
glycolipid in nature and is not closely related to LAM
since protease K digestion and treatment with anti-LAM
antibody had no effect on activity.

Similar

interpretation of the ACN MPARA MSPD fraction is less
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clear.

The data suggests that this fraction is some

combination of protein, carbohydrate and lipid?
however, based on other data the protein component is
either minimal or absent (minimal amounts of protein in
the ACN fraction [Table 1], no protein staining in the
ACN < 30 Kd fraction which retains activity [Figures 4
and 5], possible contamination and/or esterase activity
of protease K and the chromatographic pattern on TLC
[Figure 6]).
When the < 30 Kd ACN active fraction was analyzed
by SDS-PAGE, no bands were observed (Figure 5)
suggesting that the compound was not protein or
carbohydrate in nature.

However, analysis of the

fraction by TLC demonstrated a large band with a very
faint smaller band with higher relative mobility
(Figure 6).

This suggests the fraction contains a

mixture of two compounds (although it is almost pure)
that are primarily lipid or glycolipid and are quite
polar (since they dissolve in H20 ) .

Hass spectral data

of this fraction using plasma desorption mass spectral
analysis is in progress and preliminary results suggest
the possibility of a mixture of mycolic acids (data not
shown).

The finding that anti-LAM monoclonal antibody

partially reduces the inhibitory effect ( > 50%
reduction) of the ACN MSPD fraction (Figure 4) is
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somewhat of a mystery since a fairly characteristic
wide band normally stains with silver on SDS-PAGE gels
in the 30 - 35 Kd area of fcL_ leprae (26) which was not
observed in this fraction.

There is a band that was

observed in SDS-PAGE gels of the H20 MSPD extract that
is somewhat similar to those observed with LAM.
Further fractionation of the MPARA H20 MSPD
fraction was accomplished utilizing ConA-agarose
affinity chromatography to bind various mannan and
glucan-containing compounds from the sample with
elution of fractions in step fashion with increasing
concentrations of D-glucose (dextrose) as described by
Daniels and coworkers (13, 14, 15, 16).

Both the 1%

and 10% D-glucose fractions demonstrated significant
inhibitory activity (p < 0.0001 and p < 0.0001
respectively) while the column flow-through fraction
had lost essentially all activity (Figure 4).

As

demonstrated in Figure 5, the 1% D-glucose fraction
contains three major bands that stain for protein
and/or carbohydrate on SDS-PAGE (67 Kd, 31 Kd, and 5 10 Kd) and on TLC (Figure 6) the fraction also contains
three bands.

The 5 - 10 Kd band in Figure 5 appears

very close to a similarly staining and sized band
derived from JL. leprae identified by Brennan and
coworkers (26) as phosphoinositol mannosides (PIMX ).
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The other two bands are currently unknowns; however,
further fractionation and plasma desorption mass
spectral analysis is under way.

The 10% D-glucose

fractions contains two major bands (65 Kd and 31 Kd) on
SDS-PAGE analysis (Figure 5) and only one band on TLC
analysis (Figure 6).

Both SDS-PAGE and TLC analysis

suggest that the 1% and the 10% fractions have 1
compound in common, the 31 Kd band in Figure 5.

The

identity of these compounds are also unknown; however,
they must contain mannoslyated or glucoslyated
functional groups in order to bind to ConA-agarose (14,
15, 16, 17).

One would suspect that one of these

compounds would be LAM; however, monoclonal antibody to
H37Ra )L tuberculosis-derived LAM did not reduce or
eliminate M<p inhibitory activity (Figure 4) of the
parent H20 MSPD extract.

This does not rule out the

possibility that one of the compounds is in fact LAM;
however, it does suggest that either there are
significant differences in the LAM from different
mycobacterial species or that the M«p inhibitory
activity is not due to LAM.
In conclusion, the data presented here suggests
that as many as three compounds that exhibit
significant inhibition of M<p killing of CA are present
in Mycobacterium parflfcufrejrcuJlflais strain 18, all of
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which appear to be primarily glycolipid or some
combination of protein, lipid and/or carbohydrate.
This biological activity is extremely important in that
these compounds are likely responsible for the ability
of mycobacteria to survive the cellular defense
mechanisms of the host macrophages.

Candidacidal

activity in murine macrophages has been shown to be
enhanced by pre-incubation with IFNt (62).

The

candidacidal substance produced by these macrophages
was suggested to be a heat-stable, non-cationic
protein-like compound that is generated only in the
strong acidic environment of the phagolysosome and is
independent from oxygen reactive molecules (62).

Since

the above mentioned MPARA compounds suppress
candidacidal activity of Mip, the possibility exists for
interference with IFNt activation, decreased
acidification of phagolysosomes and subsequent decrease
in production and/or secretion of the candidacidal
substance in bovine macrophages.

Further research is

necessary and currently underway to elucidate the
structure and identity of these specific compounds.
When these compounds are obtained in purity and
identified structurally, they will be useful tools in
elucidating the mechanism/s by which macrophage-ki11ing
is inhibited and modulation of the immune response.
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Table 1.

Distribution of JLl. paratuberculosis proteins

in triplicate MSPD extracts by Markwell protein
determination.

MSPD extract

Protein (mg/ml)

Hexane

0.00 +/-0.000

Methylene chloride

0.94 +/-0.396

Acetonitrile

0.08 +/-0.023

Methanol

0.44 +/-0.040

h 2o

0.99 +/-0.260

Means +/- standard deviation are presented.

CFU Candida albicans
0

5

10

15

20

25

BLANK

MeOH

Figure 1.

Inhibition of Mtp-Candida albicans killing

with MPARA fractions obtained by MSPD.

(HEX) Hexane;

(DCM) Methylene chloride; (ACN) Acetonitrile; (MeOH)
Methanol; (H20) H20; (BLANK) Standard buffer.

<a ' b '

c ) = Bars with different letters are significantly
different at p < 0.01.

(n=6)
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Figure 2.

67 KD

< m

*****

30 KD

>n.

il" '

HI

.

20 KD

Proteins of iL. paratubercu1osis MSPD

extracts as demonstrated by a silver stained SDS-PAGE
gel (Wray). (1) HX extract; (2) DCM extract; (3) ACN
extract; (4) MeOH extract; (5) H20 extract; Molecular
weight standards (Low molecular weight calibration kit,
Pharmacia-LKB).
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Figure 3.

Proteins and carbohydrates of M.

paratubercu1os is MSPD extracts as demonstrated by a
silver stained SDS-PAGE gel (Tsai and Frasch).
extract; (2) DCM extract; (3)

(1) HX

ACN extract; (4) MeOH

extract; (5) H20 extract; Molecular weight standards
(Low molecular weight calibration kit, Pharmacia-LKB).
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CFU Candida albicans
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BLANK
ACN
H20
BLANKC
ACNC
H20C
BLANKM
CNM
20M
BLANKP
ACNP
H20P
H20F - \ m '
H20 1 % --H2010%
BLANKL
ACNL
H20L
A3<30KD
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Figure 4.

60

_i_

d.e.f.g.h.l

c,d,e,f

c.d.e
a.f.g.n.l
a,b

Inhibition of Mto-Candida albicans killing by

MPARA enzymatically and chemically treated MSPD
fractions.

(ACN) Acetonitrile extract; (H20) H20

extract; (BLANK) Standard buffer; (C) Chloroform
extracted; (M) Metaperiodate treated; (P) Protease K
digested; (L) Reacted with anti-LAM antibody; (F)
Column flow-through; (1%) ConA-agarose 1% dextrose
eluate; (10%) ConA-agarose 10% dextrose eluate;
(ACN<30KD) Less than 30 Kd fraction of ACN MSPD
extract;

(a • b '

= Bars with different letters are

significantly different at p < 0.01. (n = 4)
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Figure 5.

SDS-PAGE gel of partiallly purified

macrophage inhibitory fractions derived from the ACN
and H20 MPARA MSPD fractions.

Stained with silver to

demonstrate protein and carbohydrate (Tsai and Frasch).
(1) = ACN < 30 Kd fraction; (2) 1% Dextrose ConAagarose H20 MSPD extract; (3) 10% Dextrose ConA-agarose
H20 MSPD extract.

Molecular weight standards (Low

molecular weight calibration kit, Pharmacia-LKB).

Figure 6.

Thin layer chromatography of MPARA MSPD

extracts, ACN centrifugal filtration fractions and
ConA-agarose affinity chromatography derived active
fractions from the H20 MSPD extract (mobile phase 50%
chloroform/40% methanol/10% H20).

(A) HX extract; Lane

(B) DCM extract; (C) ACN extract; (D) MeOH extract; (E)
H20 extract; (F) ACN > 30 Kd fraction; (G) ACN < 30 Kd
fraction; (H) 1% Dextrose ConA-agarose H20 fraction;
(I) 10% Dextrose ConA-agarose H20 fraction.
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CHAPTER 6

SUMMARY AND CONCLUSIONS

Fractions exhibiting activity detrimental to the
killing function of activated bovine monocyte/
macrophages for Candida albicans were obtained from
Mycobacterium paratuberculosis.

Active fractions were

initially derived by ultrasonication of bacterial
samples followed by ammonium sulfate precipitation,
ion-exchange chromatography, gel filtration
chromatography, heat precipitation, acid precipitation
and alkali treatment.

Two different fractions that

exhibited marked inhibition of macrophage killing
ability were derived; (1) 25-50% AS 0.2M-0.5M NaCl DEAE
Sephacryl HR-200 fractions #1 & #2 and (2) 25-50% AS
0.2M-0.5M NaCl DEAE Sephacryl HR-200 fractions #5 & #6.
The factors were extremely heat-stable, acid-stable and
alkali-stable and were probably some combination of
protein, lipid and carbohydrate (i.e.,
peptidoglycolipid, glycoprotein, glycolipid).

The

initial work also suggested the need to develop more
efficient and less time-consuming methodology for
isolation and characterization of the factors.
Novel methodology was applied to accomplish the
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task of lysis and fractionation of mycobacteria
utilizing the Matrix Solid Phase Dispersion (MSPD)
technique. This technique appears to be much more
efficient and is certainly less time-consuming and less
expensive than classical methodologies.

Lysis was

confirmed by scanning electron microscopy and by the
presence of high molecular weight compounds in solvent
fractions that could not have escaped from the cell
without membrane lysis (i.e. DNA).

Fractionation of

cellular components were confirmed by analysis of the
solvent extracts by SDS-PAGE, Markwell protein
determination, HPLC and GC/MS.
By making minor modifications in the MSPD
technique both genomic and plasmid DNA could be
obtained in partial purity.

The DNA samples were

further purified using classical means to obtain DNA
that was amenable to restriction endonuclease digestion
with yields comparable to those of classical means.
This finding should greatly ease the difficulty of
obtaining DNA from various strains of mycobacteria.
Although equally applicable to other more easily
disrupted bacteria (i.e. JLs. coli), the MSPD technique
for obtaining DNA is probably not an advantage over
classical techniques.
By utilizing the MSPD technique for lysis and
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fractionation of mycobacteria, two MSPD fractions from
M. paratuberculosis demonstrating marked inhibitory
activity towards the killing function of macrophages
have been obtained (ACN and H20 MSPD extracts).
Further fractionation by centrifugal filtration and by
Concanavalin A affinity chromatography have
demonstrated as many as three compounds that show
activity.

When the ACN < 30 Kd fraction was analyzed

by SDS-PAGE, no bands were observed (Figure 5)
suggesting that the compound was not protein or
carbohydrate in nature.

However, analysis of the

fraction by TLC demonstrated a large band with a very
faint smaller band with higher relative mobility.

This

suggests the fraction contains a mixture of two
compounds (although it is almost pure) that are
primarily lipid or glycolipid and are quite polar.
Mass spectral data of this fraction using plasma
desorption mass spectral analysis is in progress and
preliminary results suggest the possibility of a
mixture of mycolic acids.
Further fractionation of the MPARA H20 MSPD
fraction utilizing ConA-agarose affinity chromatography
to bind various mannan and glucan containing compounds
from the sample demonstrated two fractions with
macrophage inhibitory activity.

Both the 1% and 10% D-
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glucose fractions demonstrated significant inhibitory
activity while the column flow-through had lost all
activity.

The 1% D-glucose fraction contains three

major bands that stain for protein and/or carbohydrate
on SDS-PAGE (67 Kd, 31 Kd, and 5 - 1 0 Kd) and on TLC
the fraction also contains three bands.

The 5 - 10 Kd

band appears very close to a similarly staining and
sized band derived from

leprae identified by Brennan

and coworkers as phosphoinositol mannosides (PIMj^).
The other two bands are currently unknowns; however,
further fractionation and plasma desorption mass
spectral analysis is under way.

The 10% D-glucose

fractions contains two major bands (65 Kd and 31 Kd) on
SDS-PAGE analysis and only one band on TLC analysis.
Both SDS-PAGE and TLC analysis suggest that the 1% and
the 10% fractions have 1 compound in common, the 31 Kd
band.

The identity of these compounds are also

unknown; however, they must contain mannoslyated or
glucoslyated functional groups in order to bind to
ConA-agarose.

One would suspect

compounds would be LAM;

that one of these

however,monoclonal antibodyto

H37Ra |L tuberculosis derived LAM did not reduce or
eliminate M<p inhibitory

activity of the parent H20MSPD

extract.

rule out that one of the

This does not

compounds is in fact LAM; however, it does suggest that
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either there are significant differences in the LAM
from different mycobacterial species or that the M<p
inhibitory activity is not due to LAM.
In conclusion, the data presented here suggests
that as many as three compounds that exhibit
significant inhibition of M<p killing function are
present in Mycobacterium paratuberculosis strain 18,
all of which appear to be primarily glycolipid or some
combination of protein, lipid and/or carbohydrate.
This biological activity is extremely important in that
these compounds are likely responsible for the ability
of mycobacteria to survive the cellular defense
mechansims of the host macrophages.

Further research

is necessary and currently underway to elucidate the
structure and identity of these specific compounds.
When these compounds are obtained in purity and
identified structurally, they will be useful tools in
elucidating the mechanism/s by which macrophage-ki11ing
is inhibited and modulation of the immune response.
is hoped that this work has expanded the knowledge
available in the molecular pathogenesis of ruminant
paratuberculosis (Johne's Disease) and partially
elucidates some of the factors involved in the
intracellular survival of mycobacteria and possibly
other pathogens that reside within macrophages.

It
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